GFN News: Recent Episodes
GFN.TV
Since 2014, the Global Forum on Nicotine (GFN) has been the only international conference to focus on how safer nicotine products like vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking, in an approach called tobacco harm reduction.
Building on the event's success, GFN•TV launched in 2022 with GFN News hosted by Joanna Junak. Each episode, Joanna's bulletin shares tobacco harm reduction updates from around the world alongside brief expert interviews. After the news, Joanna hands over to Brent Stafford, who hosts the in-depth GFN•TV/RegulatorWatch discussion segment with a variety of expert guests.
Available to watch at https://gfn.tv and now to listen on [Soundcloud / Spotify / Apple Podcasts], GFN News ensures that our platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction is accessible to a global audience all year round. Tune in now!
https://gfn.events | Follow us on social media! @GFNicotine
How do people actually transition between different nicotine products over time? Are young people who experiment with e-cigarettes more likely to become smokers, and is dual use a long-term pattern or simply part of the journey away from cigarettes?Drawing on a decade of data from the U.S. Population Assessment of Tobacco and Health (PATH) Study, this presentation explores how nicotine product use changes among both underage and adult populations. Using longitudinal evidence that follows the same individuals over time, it examines real-world transitions between cigarettes, smoke-free products, dual use, and non-use.
The debate over prohibition often focuses on intentions, but the real question is whether restrictive policies achieve their public health goals. As governments around the world consider tighter controls on nicotine and tobacco products, evidence continues to raise important questions about the unintended consequences of prohibition, including the growth of illicit markets, the role of organized crime, lost tax revenue, and reduced access to lower-risk alternatives for adults who smoke.
How much nicotine remains in a nicotine pouch after months of storage? And can formulation design improve long-term stability?In this presentation, Anna Balconi explores preliminary research comparing conventional microcrystalline cellulose (MCC)-based nicotine pouches with a novel semi-gel-based formulation developed by Alchem NicSelect. The study examines how nicotine content changes over time and investigates whether different pouch architectures can reduce degradation caused by oxidation and evaporation.
Despite decades of prohibition, smoking remains one of the leading preventable causes of disease and death worldwide. So why do policies that restrict safer alternatives often fail to improve public health?Leading experts examine the unintended consequences of prohibition, arguing that banning lower-risk nicotine products does not eliminate demand—it simply shifts consumers toward illicit markets and more harmful products. Drawing on real-world examples from countries including Brazil, Mexico and the United States, they discuss how restrictive policies can undermine public health objectives, fuel illegal trade, and make product regulation more difficult.
What’s really inside nicotine pouches? While these products are often treated as a single category, their composition can vary significantly.In this GFN Science Lab presentation, Lindsay Reese presents one of the largest compositional analyses of nicotine pouches to date, covering 446 fully tested products from 2025 (drawn from more than 500 products analyzed). The research explores key characteristics such as nicotine content, moisture, pH, impurities, heavy metals, and other chemical constituents, offering a detailed look at the diversity of products available across global markets.
What are the fundamental principles of harm reduction and how can they be applied to many areas of human activity? How can tobacco harm reduction be integrated into mainstream practice to reduce the harms of smoking for those most at risk – illicit drug users, those with poor mental health and others marginalised through economic and legal constraints? What are the obstacles to integration and how might we address and overcome these?
Among more than 100,000 people who used heroin in England, smoking accounted for 24% of premature deaths, nearly matching illegal drugs at 28%. Yet smoking remains routinely overlooked within drug treatment and harm reduction services. Shot on location at GFN 2026 in Warsaw, Poland, David MacKintosh of the Global State of Tobacco Harm Reduction explains how integrating safer nicotine could deliver a low-cost, high-impact intervention that helps people live longer and healthier lives.Featuring:DAVID MACKINTOSHDirector, Knowledge Action Change Fmr. Chair of Trustees, Drug and Alcohol Services London kachange.eu
Barriers to the marketing of novel tobacco and nicotine products, such as regulatory bans and restrictions, pose an existential threat to tobacco harm reduction and improving the health and lives of adult smokers. This workshop will take a dive into assessing the science base used to drive restrictions, focussing on several themes which are commonly used to push for stronger regulation or outright prohibition and presenting scientific counterarguments.
More than a billion adults globally smoke combustible cigarettes. The harm caused can be reduced if individuals switch completely to smoke-free products. Availability of a wide range of options can accelerate their switching journey. However, access to products is being restricted by either outright bans or flavour restrictions. Whilst aimed at preventing underage use, this overlooks the needs of adults who smoke. This session will focus on a rigorous, evidence-based evaluation of whether product/flavour bans achieve the objective of reducing youth use of smoke-free products, without undermining adult smokers’ access to effective switching options.
Europe is escalating its war on safer nicotine by pursuing new restrictions on vaping, nicotine pouches, flavors, and affordability despite overwhelming evidence that these products can displace smoking. Shot on location at GFN 2026 in Warsaw, Poland, Dr. Konstantinos Farsalinos describes the policy shift as a “tremendous setback.” He examines why Europe is abandoning common sense, refusing to learn from failed prohibitionist policies, and pushing a market serving millions of former smokers toward illicit trade. Featuring:KONSTANTINOS FARSALINOS, M.D.Cardiologist, Public Health ExpertUniversity of Patras, GreeceUniversity of West Attica, Greeceecigarette-research.org
This session explored the future of tobacco control in Iberoamérica, highlighting the consequences of prohibitionist and ideologically driven approaches. It will examine how such policies may overlook key public health and human rights principles by limiting access to lower-risk alternatives and failing to reflect the realities of people who use nicotine. The discussion will also consider the role of tobacco harm reduction (THR) as a more pragmatic, evidence-based approach to improving health outcomes.
Harm reduction approaches are now an established and fundamental part of the response to drug use. While tobacco harm reduction has an expanding evidence base it is often viewed in narrow terms, as if people who smoke exist in a discrete silo.This has meant the potential of THR to help communities with high smoking prevalence, such as people who use drugs, remains underexplored – despite the evident harms they experience and their impact on health outcomes.This session brings a drug harm reduction perspective to THR, drawing on frontline experience across a range of environments and sectors, seeking to highlight what works in terms of harm reduction for individuals and communities, plus opportunities for further development.
how these concepts differ in scientific and clinical contexts, and why language matters when discussing people who use nicotine.
The panel will discuss the various forms of prohibition, examine the main objections to prohibition, and ask under what circumstances, if any, prohibitions are justified. We consider the likely consequences of prohibition, especially in the counterintuitive case where prohibition applies to products safer than the market norm. What are the merits of two common strategies for addressing the costs and consequences: a stronger enforcement approach or removing the underlying economic incentives? We will conclude with an engaging finale, in which the panel and audience are asked to provide unwanted advice to the Australian government, Michael Bloomberg and the WHO.
The session will explore the economic dimensions of prohibition through a political economy lens. Drawing on data and insights from multiple markets, it considers how regulatory actions may influence consumer behaviour, demand across product categories and public perceptions. It will also examine potential fiscal effects and the dynamics of illicit trade in response to prohibition. Bringing together policy, data, and market insight, this session explores how prohibition shapes real-world outcomes for consumers, governments, and public health.
Safer nicotine products are increasingly popular for assisting those quitting smoking. Evidence continues to support the game-changing effect this can have on individual and community health. Some questions emerge from this. What should be the role of public health in this? Why do some public health professionals continue to ignore or dismiss the emerging evidence? Does ideology cloud judgements? Should personal choice and freedom be a priority? What legitimate role is there for regulation in this area?
How does prohibition of safer alternatives square with the Hippocratic oath? What are the ethics of accepting smokers' lives and wellbeing as collateral damage, in pursuit of the war on the nicotine industries? Why is giving alternatives to people who misuse substances viewed differently to permitting people who smoke access to less harmful alternatives? Supported by evidence from work successfully debunking bad science, including exposing research claims correlating viral TikTok videos about nicotine pouches to sales. Shouldn't we allow people to make informed judgements about their behaviour and their health?
THR Unfiltered #1 | Navigating the prohibitionist landscape of THR in the States by GFN.TV
What happens when governments ignore science and choose outright prohibition over evidence-based public health? In this panel discussion, international experts and harm-reduction advocates break down the global shift toward nicotine prohibition and the severe, unintended consequences of banning safer nicotine alternatives.
—and how we navigate the transition.In this video, you’ll learn:- why safer nicotine products are set to completely displace smoking soon;- the multi-layered impact of tobacco harm reduction (beyond just physical health);- the vital role advocates play in upcoming legislative battles.
From street-level corruption to billion-dollar criminal enterprises, our panel explores how prohibition fails to stop consumer demand and instead directly fuels global organized crime.
agenda.Tune in to discover why defending science-backed, safer alternatives isn't just a matter of medicine and epidemiology, but a fundamental fight for human rights and personal freedom.
In this episode, researcher Chimwemwe Ngoma breaks down a comprehensive national study analyzing the tobacco use patterns of over 30,500 adults. While an overwhelming 95% of Malawians do not use tobacco, the data reveals a stark socioeconomic divide: smoking prevalence among the poorest communities is double that of the wealthiest.Tune in to discover how factors like education and wealth influence the choice between combustible, smokeless, and dual tobacco use, and why the heaviest health burden falls on the most disadvantaged.
What does it take to implement life-saving public health programs in the Middle East and Africa? In this episode of GFN Insights, Amjad Malaeb from MENAHRA shares the critical challenges and breakthroughs of harm reduction in this region.In this interview, public health expert Amjad Malaeb dives into his five-year journey working with the Middle East and North Africa Harm Reduction Association (MENAHRA). Amjad discusses how the organization has expanded its scope from HIV-focused harm reduction for people who use drugs to a holistic healthcare approach addressing tuberculosis (TB) and hepatitis. Discover the harsh realities of navigating complex political and security landscapes, the critical role of stakeholder and community engagement, and how the Global Fund MENA Learning Hub is empowering local communities with essential knowledge.
plan destined to backfire?In this episode of GFN News, host Zuzanna Kopacz sits down with author and freelance writer Jacob Grier to unpack the practical realities and hidden dangers of the newly passed UK Tobacco and Vapes Bill.While the policy aims to create a smoke-free generation by phasing out legal tobacco sales for anyone born after 2009, Grier argues that the legislation ignores the needs of current smokers. Worse yet, by introducing sweeping bans on vape advertising and targeting alternative nicotine flavors, the bill threatens to shut down the very pathways that help smokers successfully switch to lower-risk harm reduction products.
Despite low female smoking rates in the country, women face unique, hidden challenges when trying to access safer nicotine alternatives. Hannah shares her personal and professional motivations for bringing these voices to light , highlighting the critical gaps in policy, education, and market regulation that leave Malawian women behind.
Twenty years after the WHO’s Framework Convention on Tobacco Control came into force, has the treaty lost its way? According to Jeannie Cameron, the answer is yes. Cameron is a tobacco policy expert with a background in international law who observed the FCTC negotiations from the beginning. She says a treaty once focused on reducing smoking-related disease has morphed into a global system hostile to tobacco harm reduction. From NGO influence and prohibitionist thinking to the demonization of safer nicotine products, tobacco control has drifted far from its original purpose and now risks lives.Featuring:JEANNIE CAMERONCEO/Managing Dir., JCIC International ConsultancyFmr. V.P. International, Juul LabsFmr. Head of International Advocacy, BAT@JCICJeannie
of random testimonials often fails to move the needle. By extracting specific data points - like smoking history, failed quit attempts, and product usage - THR Global is turning individual stories into a structured, global evidence base that policy makers can no longer overlook.
and a constitutional prohibition on vaping, Miguel explains why providing evidence-based information is more than a choice - it's a necessity for public health.
Today we explore the rise of harm reduction across the Middle East and North Africa through the story of MENAHRA and the activists, healthcare workers, and organizations fighting stigma, HIV, and outdated drug policies. In regions where addiction and public health issues are often heavily stigmatized, harm reduction became more than healthcare — it became a movement for human rights and survival.
For too long, the voices of nicotine consumers have been sidelined, silenced, or willfully excluded from the global policy stage. From WHO COP meetings to local regulations, the people most impacted by these decisions are often the only ones without a seat at the table.In this episode of GFN News, Zuzanna Kopacz speaks with Will Godfrey, Editor of Filter, about the launch of THR Global. This new platform is more than just a website—it is a mission to reclaim the narrative through the power of lived experience.
In a years-long campaign to eradicate smoking, Australia’s tobacco control establishment has lost all control of the nicotine market. Former law enforcement officer Rohan Pike says 70–80% of the tobacco market is now illicit, while roughly 95% of vaping has been pushed into criminal hands. The founder of Australia’s first Tobacco Strike Team explains how excessive taxes, vape prohibition, and policy denial empowered organized crime. Featuring:ROHAN PIKEIllicit Trade Advisor, Sr. Australian Federal Police Officer,Founder, Tobacco Strike Teampikeconsulting.com.au
In this episode of GFN Insights, we sit down with Marceline Akinyi to discuss the complex landscape of nicotine education and public health in Kenya. As the country faces a wave of product bans, Marceline highlights a dangerous gap between academic research and public understanding.
In this episode of GFN Insights, Jon Derricott from Knowledge Action Change (KAC) joins Joanna Junak to discuss the development of the Global State of Tobacco Harm Reduction (GSTHR) image library.Hosted on Flickr, this unique initiative aims to document the rapidly evolving world of tobacco and nicotine products. From modern vape shops to traditional tobacconists and local products like gutka or negrimbo, the library serves as a vital, royalty-free resource for activists, journalists, and presenters worldwide.
One of the world’s leading harm reduction advocates sees disaster unfolding in Australia. Sky-high tobacco taxes and sweeping restrictions on nicotine vaping were meant to reduce harm—but instead, they’ve fueled a booming illicit market, siphoned billions in public revenue, and triggered a wave of violence tied to organized crime. In this GFN Interviews, Dr. Alex Wodak explains how Australia’s approach has veered into “quasi prohibition,” driving demand into the black market and overwhelming enforcement.Featuring:DR. ALEX WODAKPhysician, Internal MedicineFormer Director, Alcohol and Drug ServicesSt Vincent’s Hospital, SydneyBoard Member, Australian THR Association@AlexWodak
and agency narratives often overshadow inconvenient truths about safer nicotine alternatives.- Common Liability: Understanding why researchers believe the correlation between vaping and smoking is misunderstood by mainstream tobacco control.As youth smoking rates hit unprecedented lows, we ask: Why are the entities tasked with protecting public health stoking alarmism instead of acknowledging this historic decline?
campaign. We dive deep into why treating vaping the same as smoking isn't just scientifically flawed—it's a massive risk to public health.- May 8, 2026 (11:59 PM): Deadline to submit your response to the government consultation.- October 1, 2026: New vaping taxes and business regulations are set to begin.Take Action: Your voice matters! Visit SaveVaping.org to find resources on how to respond to the consultation and contact your MP. Don't let misinformed legislation undermine years of progress in harm reduction.
Australia’s vape crackdown was supposed to curb youth use—but in practice, it has created prohibition by proxy. While still legal, access to nicotine vapes is tightly controlled and choice is so severely limited that over 90% of all vapes in Australia are purchased on the black market. In this episode of GFN Interviews, Australian GP Dr. Carolyn Beaumont examines how this system frustrates access to safer nicotine—from restrictive product approvals to medical guidelines that offer little real support for harm reduction.Featuring:DR. CAROLYN BEAUMONT, MDAustralian General Practitioner/Family Physician
In this episode of the Science Series, Roberto Sussman breaks down why many lab studies on e‑cigarette emissions can’t be trusted—and how bad testing setups can create misleading “high toxin” results. He explains the “optimal regime” for vaping devices (power, resistance, airflow), why reproducibility requires full reporting of test conditions, and how unrealistic puffing machines can cause overheating and artificially inflate byproducts.You’ll also learn why using obsolete devices (or poorly stored old hardware) ruins conclusions, and how a common toxicology mistake—calculating concentrations in the puff volume instead of the air a person actually inhales—can overestimate exposure by 10–20×. Roberto shares a simple traffic‑light approach to grading studies (green/credible, yellow/questionable, red/reject) and why the most alarming results often come from the weakest methodologies.
“Why have some studies reported enormous amounts of formaldehyde and metals in vaping emissions?”In this episode of Science Series with Roberto Sussman, we break down how those scary numbers can come from bad experimental conditions—especially overheating setups that don’t reflect how people actually vape. Roberto explains why “micrograms per puff” can be misleading, how to translate emissions into realistic daily exposure (based on typical puff counts), and how those totals should be compared against toxicological standards published by regulators.You’ll also hear why properly designed tests tend to find toxic byproducts far below cigarette smoke—and often below common benchmarks, with a reality-check comparison to everyday aerosols and even air pollution exposure.
Governments insist their nicotine policies are “evidence-based.” But a closer look reveals cherry-picked findings, flawed comparisons, and sensational claims that don’t withstand scrutiny. In this GFN interviews, independent tobacco scientist Dr. Ian Fearon explains how weak research and distorted interpretations shape global nicotine policy. From the misuse of correlation to media amplification of questionable studies, Fearon shows how flawed science fuels prohibitionist thinking—leaving smokers misinformed about safer alternatives that could reduce the harms of smoking.Featuring:DR. IAN FEARONDirector, Independent Research ScientistwhatIF? Consulting, UK
In this episode of GFN News, Joanna Junak speaks with Will Godfrey of Filter about Germany’s proposed regulation to ban flavoured e-liquids containing cooling agents.The draft measure would prohibit menthol and other “iced” vape products that rely on cooling additives. Supporters of the proposal, including Germany’s Federal Institute for Risk Assessment, argue that cooling effects may make vaping easier to inhale and potentially increase nicotine intake - particularly among young and inexperienced users.
GFN25 Science Discussion #17 | How to Avoid Pitfalls in Observational E-Cigarette Health Research by GFN.TV
In this episode, we unpack the hidden environmental cost of vaping - from millions of discarded devices and batteries to ecosystem contamination - and why awareness isn’t translating into action. The conversation highlights a major gap: many users recognize the harm, but far fewer know how (or where) to recycle, and only a minority actually do.We also explore what could change the outcome: clearer product labeling, education that’s practical (not fear-based), better recycling infrastructure, and shared responsibility between governments, manufacturers, retailers, and users—moving toward a circular-economy approach to nicotine products.
In this GFN News interview, Aylen Van Isseldyk (creator of the global research project Circular Vape Recycling) explains the hidden environmental impact of vaping devices—from hard-to-degrade plastics and lithium batteries to the structural barriers that make e-cigarette recycling so difficult.We also discuss why awareness alone isn’t enough, what manufacturers and institutions can do (eco-design, modular/reusable devices, and extended producer responsibility), and how users can help by returning devices to collection points and choosing more sustainable options.
Join us at the Global Forum on Nicotine 2026 in Warsaw and be part of the only truly open conference on safer nicotine, tobacco harm reduction and the real impacts of prohibition on public health. Hear leading scientists, clinicians, ethicists and advocates discuss social, health and economic consequences of bans, explore strategies to reach marginalized groups, and discover the latest research in our popular Science Lab sessions. Keynotes from pioneers like Dr Alex Wodak and other international experts, plus multilingual streaming and a dedicated Spanish-language session, make GFN 2026 a must-attend event for anyone serious about nicotine policy and harm reduction.Ready to join the discussion? Visit GFN.EVENTS to register!
Public health says it wants to end smoking. Yet from London to Brussels, policymakers are advancing measures that treat safer nicotine like combustible tobacco—through high taxes, public bans, and regulatory equalization. In the UK, the Tobacco and Vapes Bill hands sweeping powers to the Secretary of State. In the EU, new tax schemes could bind member states and redirect national excise revenue to Brussels. In this GFN interviews, Martin Cullip argues these measures converge into what he calls “pro-smoking” policy—undermining harm reduction, eroding national sovereignty, and putting millions of adult consumers across Europe at risk.Featuring:MARTIN CULLIPIntl. Fellow, Taxpayers Protection Allianceprotectingtaxpayers.org@Protectaxpayers@NannyFreeState
UK disposable vape ban: what’s changed, what hasn’t, and what’s next? In this episode of GFN News, Joanna Junak speaks with John Dunne (UK Vaping Industry Association) about how the market is responding to new regulation - rising black market activity, the shift from disposables to pod/open-tank systems, and why consumer behavior (including recycling) is still a challenge. They also address public confusion about relative harm compared to smoking, concerns around youth uptake, and why nicotine pouches may grow as an alternative in places where vaping isn’t practical.
GFN25 Science Discussion #16 | Use Studies Demonstrating the Significant THR Potential of blu Vapes by GFN.TV
In this episode of Science Series with Roberto Sussman, we tackle a deceptively simple question: how do you determine optimal vaping settings in a laboratory? Roberto explains why machine “puffing” can produce unrealistic overheating conditions that real users would immediately avoid (too hot, bad taste), and how that can distort measurements and conclusions in some studies. We also cover the “dry puff”/dry heat phenomenon, why airflow and power settings matter, and how modern devices differ from early closed “cigalike” systems.
In today's Science Lab session, Sam Hampsher-Monk (ARAC), explores how person-centered thinking applies to the global nicotine and tobacco policy landscape. He explains how effective harm reduction depends not only on the availability of safer alternatives but also on consistent, evidence-based public health messaging. #GFN25ScienceLab
Todd Prochnau presents a pharmacist's review of Canadian guidance on alcohol consumption and how the principles of patient-centred care and informed decision making can be applied to both alcohol and nicotine products.
Sweden’s smoke-free success is often credited to snus, but that’s only half the story. While snus appealed to many men looking to quit smoking, for women the smell, taste, and feel left something to be desired. For years, women were left without a viable alternative. That changed with nicotine pouches. Tobacco-free, discreet, and socially acceptable, they became the missing solution. In this GFN Interviews, Carissa Düring explains why nicotine pouches didn’t just complement the Sweden Model, they completed it, delivering the silver bullet public health refuses to acknowledge.Featuring:CARISSA DÜRINGDirector, Considerate Pouchers SwedenConsumer Advocateconsideratepouchers.org@carissaduring
In this video, Joanna Junak speaks with Juan José Cirión Lee, president of Mexico y el Mundo Vapeando, about the growing restrictions on vaping in Mexico. They discuss how the new ban impacts harm reduction efforts, limits public access to information, and challenges organizations working to support smokers seeking alternatives.Hear firsthand insights on the future of vaping, public health policy, and advocacy in an increasingly restrictive environment.
In this episode of GFN News, we break down Mexico’s strict new regulations on vaping, including bans on marketing, sales, and imports—and the possibility of prison sentences for violations.Joined by Juan José Cirión Lee, a legal expert and advocate for harm reduction, the discussion explores what the law actually allows, what remains unclear, and how these changes could impact consumers and public health.Is vaping truly illegal in Mexico, or is it still a legal gray area? Watch to understand the real implications of this controversial policy shift.
Bangladesh has introduced sweeping new restrictions on nicotine products, including vapes and pouches - extending penalties even to personal use. In this interview, Will Godfrey of Filter breaks down what the law means, its public health implications, and why critics warn it could fuel illicit markets and harsher enforcement.
GFN25 Science Discussion #13 | HTP Use Patterns and verified smoking status in HTP customers by GFN.TV
Behavioral science consultant Arielle Selya joins GFN News to discuss her new YouTube channel and why she’s breaking down tobacco harm reduction research. From misperceptions about vaping to the gateway hypothesis, she explains what the science actually shows—and how studies are often misrepresented.
A massive opportunity to reduce smoking-related death is being squandered. In this episode of GFN Interviews, cardiometabolic physician Dr. Rohan Sequeira examines how public health distorts the public’s understanding of nicotine and risk. With South Asia bearing an enormous tobacco burden, he explains why traditional cessation approaches are failing, why safer nicotine products matter, and how misinformation continues to block harm reduction. Featuring:DR. ROHAN SEQUEIRACardio Metabolic Physician, Non-Invasive Cardiology Medical Director, St. Elizabeth Hospital Mumbai @rohseq
In our next Science Lab session Dr Marewa Glover presents the key findings of the Voices of the 5% Study, a 4-year longitudinal qualitative study of New Zealand adults who used vapes but had no intention of quitting smoking.
In Part 2, Bengt Wiberg explains why EU nicotine policy should be science-based, not political. Drawing on Sweden’s success, he challenges cancer myths, youth claims, and makes the case for smart regulation to reduce smoking and save lives.
EU nicotine policy is under fire after claims that smoke-free nicotine products are as harmful as cigarettes. In GFN News, Joanna Junak interviews Bengt Wiberg of Stingfree AB on why experts dispute these statements, what science says about nicotine pouches, snus, and vaping, and how the debate could impact tobacco harm reduction and future EU regulation.
2026 could be a turning point for nicotine policy in Africa. In this episode of GFN News, Joanna Junak speaks with Joseph Magero, consumer advocate and Chairman of the Campaign for Safer Alternatives, about the challenges and opportunities for harm reduction, the impact of restrictive policies, and how countries like South Africa, Kenya, and Nigeria are shaping the future of safer nicotine products.Topics Covered:- Harm reduction vs tobacco control in Africa- Regulation of vaping, heated products, and nicotine pouches- Black market impacts and public health concerns- How misinformation affects policy decisionsStay informed on Africa’s nicotine policy landscape and what it means for smokers and regulators.
GFN25 Science Discussion #11 | Research gaps, priorities and advocate readiness for THR in LMICs by GFN.TV
Giusy Rita Maria La Rosa's systematic review and network meta-analysis of 36 randomised contol trials examines the oral health effects of non-combustible nicotine products. Dr Riccardo Polosa takes questions from GFN25 attendee's.
A new European Heart Journal report has reignited the debate over nicotine, heart health, and harm reduction. In this GFN News interview, Will Godfrey of Filter examines the claims that all forms of nicotine pose equal cardiovascular risk and the strong backlash from independent experts.The discussion explores criticisms of the report’s scientific approach, evidence from population studies, and concerns that its conclusions could influence upcoming EU tobacco, taxation, and health policies. With Europe already facing the world’s highest smoking rates, the video asks whether this narrative could undermine harm reduction efforts and discourage smokers from switching to less harmful alternatives.
In another Science Lab session Dr Roberto Sussman provides a critiques of e-cigarette aerosol studies and discusses the methodological problems that persist with emission studies, such as overheating coils to produce aldehydes and manufacturing harms.
Six months after the UK’s disposable vape ban, questions remain over its real-world impact. Industry commentator Martin Cullip discusses weak enforcement funding, the rise of illegal sales, growing environmental awareness, and concerns that the ban could undermine smoking cessation and push some users back to cigarettes.
Part two of the interview will air on Wednesday, January 14th!Join Joanna Junak and Martin Cullip as they break down the UK Tobacco and Vapes Bill, expected to become law in 2026. We explore the generational smoking ban, vaping and nicotine regulations, and potential impacts on adult users. Learn why nicotine pouches, flavor restrictions, and ministerial powers are sparking debate, and how consumers and harm-reduction advocates can make their voices heard.Stay informed about the latest UK tobacco and vaping policies and what they mean for smokers, vapers, and the future of safer nicotine products.
America’s tobacco policy has turned self-destructive. Safer nicotine products are demonized and restricted while combustible cigarettes remain widely available. In this GFN interview, Michelle Minton of the Reason Foundation explains how fear, ideology, and institutional incentives replaced evidence in U.S. tobacco control—pushing consumers back toward smoking and undermining one of the greatest public-health opportunities of our time. Featuring:MICHELLE MINTONManaging Director, Drug PolicyReason Foundationreason.org@michelleminton
Green and Professor Tikki Pang share their hopes and predictions for tobacco harm reduction worldwide. From clear, science-based messaging about vaping and nicotine pouches to the dangers of prohibition and illicit products, they discuss what changes are needed - and what might realistically happen. Discover their insights on creating safer alternatives and amplifying the voice of harm reduction in public health.
In 2025, the world saw both progress and setbacks in tobacco control. Sweden became officially smoke-free through effective risk-reduction policies, while Mexico implemented strict bans on vaping and harm-reduction tools, fueling black markets and uncertainty. Meanwhile, countries like Chile are leading the way with regulations that recognize safer alternatives.
In this video, experts Carmen Escrig and Ian Fearon discuss the global shift in tobacco harm reduction and the fight against prohibitionist policies. From Spain to the UK, brave policymakers are challenging outdated laws and advocating for science-based regulations that save lives.As we look toward 2026, there is hope for a world where adult smokers have safer alternatives and governments prioritize public health over ideology and lobbying. Discover the challenges, victories, and the growing momentum for change in tobacco regulation worldwide.
A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patterns of resistance to innovation, the importance of genuine public health principles, and the accelerating shift away from combustible cigarettes worldwide. An inspiring call to action for advocates, researchers, consumers, and industry leaders working toward a smoke-free future.
As policymakers look ahead to 2026, experts from Ireland and the United States share one clear hope for tobacco harm reduction: protect vape flavors.In this discussion, Dr. Garrett McGovern and AG Tom Miller explains why flavors are critical to keeping adults away from smoking - and why banning them could backfire, leading to higher cigarette use, including among youth. He argues that enforcing age restrictions, not eliminating flavors, is the real solution.U.S. perspectives echo this view, calling for regulatory clarity, approval of reduced-risk alternatives, and public health efforts that move smokers away from combustible tobacco.
As 2026 approaches, policymakers face a critical choice: continue repeating failed tobacco strategies or finally listen to science, consumers, and real-world evidence. In this discussion, Fiona Patten and Fernando Bueno examine why Australia’s tobacco tax revenue has collapsed, how harm reduction products like vaping are being wrongly regulated, and what countries like Sweden and New Zealand have done differently to dramatically cut smoking rates. The message is clear: less ideology, more evidence and a smarter, risk-based approach to public health.
Join us for a fast-moving roundup of the most significant tobacco harm reduction developments of 2025. From FCTC COP11 controversies and global bans to new scientific insights, advocacy efforts, and major policy shifts, Will Godfrey breaks down the year’s biggest stories. Discover where progress is being made, where setbacks continue, and how real-world consumers are shaping the future of safer nicotine.
Join GFN.TV and Michael Landl from the World Vapors Alliance as they break down COP11’s impact on tobacco harm reduction. Discover how countries challenged WHO recommendations, delayed restrictive measures, and pushed for evidence-based policies. Learn what this means for EU regulations, harm reduction strategies, and the global fight for safer nicotine alternatives.
Join Joanna Junak on GFN News as she speaks with Kurt Yeo, co-founder of Vaping Saved My Life, about the key moments and conversations surrounding COP11. Kurt shares his impressions from the unofficial Good COP 2.0 meeting in Geneva and offers insights into the broader discussions on harm reduction and tobacco policy.
Next in our Science Lab sessions, Chloe Rose PhD presents on the importance of properly designed studies and trials to determine the safety and relative risk of nicotine products.
In this exclusive GFN News interview, Joanna Junak speaks with Nancy Loucas, CAPHRA Executive Coordinator, about the fallout from COP11 in Geneva and the controversial Dirty Ashtray Award given to New Zealand.Despite achieving significant reductions in smoking through regulated vaping and progressive harm reduction policies, New Zealand was criticized by the WHO FCTC Secretariat and its supporting NGOs. Nancy explains why this award reflects a shift away from evidence-based public health priorities and highlights the growing tension between harm reduction strategies and prohibitionist tobacco policies.
Misunderstanding nicotine delivery: a discussion on nicotine pouches. PMI's Carrie Wade and Gizelle Baker discuss the problems with comparing nicotine content of pouches with combustible tobacco. #GFN25 Science Lab discussions
This GFN Voices 2025 episode brings together advocates, scientists and campaigners from around the world to share why the Global Forum on Nicotine matters, how tobacco harm reduction is being misunderstood, and why honest communication, access to safer products and open debate are essential for helping people move away from smoking.
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
Former Iowa Attorney General Tom Miller—America’s longest-serving AG and a principal architect of the Master Settlement Agreement—joins GFN.TV with a clear warning: the U.S. is making extraordinary progress against combustible tobacco, yet the public isn’t hearing about it. Smoking has collapsed to historic lows, youth vaping has fallen 70% since 2019, and millions of adults have shifted to far safer non-combustible nicotine products. By any honest measure, it’s one of the most significant public-health successes in decades. So why isn’t tobacco control talking about it? Featuring:TOM MILLERFormer Iowa Attorney General Founder, Miller Monitoring and Consulting, LLC.
Nigeria is experiencing increasing health impacts from smoking, and experts argue that harm reduction—not prohibition—is key to saving lives. In this GFN News episode, Joanna Junak interviews Uche Olatunji and Yusuf Adebisi on the major barriers to tobacco harm reduction in Nigeria, including widespread misinformation about nicotine and a lack of educational resources. They discuss community outreach, science-based alternatives, and the critical roles of universities and the media in shifting public perception. Learn how evidence-based harm-reduction strategies can help Nigerians make safer, informed decisions.
The media play a key role in shaping debates around THR. It is essential that information they communicate is accurate and reflects science and evidence. Misinformation and the impact it can have on consumers, and public health generally, is something we should avoid. A lack of knowledge, expertise and time to verify information provided – often by NGOs that allege to be working on behalf of public health – can lead to damaging narratives that serve nobody’s interest. How can we foster positive relationships with media to represent THR accurately and challenge those who seek to undermine it?
Ireland has introduced the highest vape tax in the European Union — but experts warn it could backfire. In this episode of GFN News, Joanna Junak speaks with Will Godfrey of Filter about how the new €0.50/ml levy may reduce switching, misinform the public, and even risk increasing smoking rates. Advocates argue the policy hits low-income groups hardest and undermines Ireland’s public health goals.
As the WHO FCTC COP11 conference approaches, Joanna Junak speaks with tobacco policy expert Clive Bates on GFN News about the growing divide between science and ideology in global tobacco control. Bates warns that prohibitionist approaches risk fueling black markets and ignoring proven harm reduction strategies. Watch now to hear his call for a new evidence-based direction in nicotine and tobacco regulation.
Discover the real science behind effective vaping.In this episode, Joanna Junak talks with vaping science researcher Roberto Sussman about how power, airflow, and resistance shape vapor production, flavor, and efficiency. Learn why temperature control isn’t the key factor—and how adjusting wattage, coil resistance, and airflow settings can completely change your vaping experience.We explore:🔥 How power affects vapor density and flavor💨 Why airflow and mouthpiece design matter⚙️ How resistance acts as a proxy for temperature🧪 Why understanding these parameters leads to safer, more consistent vapingIf you’ve ever wondered how to tune your vape for better performance, this episode explains the physics behind it all—clearly and scientifically.
Watch this insightful Spanish-language session from the Global Forum on Nicotine 2025 #GFN25 featuring experts from across Latin America and beyond. The discussion explores tobacco harm reduction (THR), the fight against misinformation, and the role of communication, science, and consumer advocacy in shaping healthier public policies.
Social worker and health policy advocate Angelica Cabrera discusses the growing movement for tobacco harm reduction across Latin America. She shares regional experiences, challenges, and success stories that highlight how alternative nicotine products could transform public health outcomes — if supported by science-based policies.
“Challenging Perceptions” — hear voices from around the world on how to communicate tobacco harm reduction effectively. From researchers to advocates, GFN 2025 brought powerful insights on evidence, empathy, and engagement.
In this presentation, Sebastian Soulet discusses the chemical processes involved in the conversion of glycerol to aldehydes during vaping. He explains how boiling regimes influence chemical reactions, nicotine delivery, and vaporization efficiency, as well as their toxicological implications.
Public health’s war on nicotine has spiraled into hysteria—untethered from science and reason. In this hard-hitting GFN Interviews, addiction specialist Dr. Garrett McGovern exposes how ideology, fear, and institutional ego are driving the misinformation crisis around vaping and safer nicotine products—and why it’s time to bring smoking harms back to the center of the debate.Featuring:DR. GARRETT MCGOVERNMedical Director, Priority Medical Clinic DublinGP Specialising in Addiction Medicine@AddictionsPMC
Development Specialist at ChemNovatic, explains the scientific process of removing aroma compounds from nicotine extract. The talk highlights ChemNovatic’s commitment to product purity and technological innovation through their proprietary STC manufacturing standard.Woźnicki discusses:- advanced purification methods for nicotine;- strategies for identifying and reducing trace impurities;- analytical techniques that ensure the highest product quality;- the importance of maintaining strict production standards in the nicotine industry.This session offers an in-depth look into modern purification technologies and showcases how science drives product safety and consistency in nicotine manufacturing.
Belgium is rapidly tightening its vaping and smoking rules — from banning disposable e-cigarettes in January 2025 to prohibiting outdoor smoking and vaping on terraces from 2027, and removing smoking rooms in bars, airports, and shisha lounges. In this interview, Joanna speaks with Alberto Gómez Hernández, Policy Manager at the World Vapers’ Alliance, about what’s changing, why it’s happening, and whether these measures.
In this interview, Maria Papaioannoy-Duic, founder and spokesperson of Rights for Vapers, speaks with Joanna Junak about the challenges Canadian vapers face in being heard in public health debates. Maria shares how her organization has worked tirelessly to educate consumers on safer nicotine alternatives, fight misinformation, and give a voice to those seeking harm reduction over prohibition.
Extending THR into other disciplines and communities, is essential. Obvious targets are in the fields of drug use and mental health - evidence is clear concerning levels of smoking and associated health risks - but there is need to engage more widely. The panel addressed the barriers to extending reach, including how can we dispel myths and tackle miscommunication? What role does the media have in the process? Who are the key opinion leaders and groups, what are the initial steps in reaching out and how can we support ongoing dialogue?
Get an in-depth look at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (FCTC) Conference, scheduled for November 2025 in Geneva. This video explores the registration process for attending the conference, the challenges faced by harm reduction groups, and the importance of consumer representation in tobacco and nicotine policy discussions.
It was perhaps inevitable that once smoking was “handled,” tobacco control would turn its fire on nicotine. From the UK’s disposable vape ban to EU pouch restrictions and the WHO’s war on nicotine, prohibition is on the march. Shot on location at GFN 2025 in Warsaw, Christopher Snowdon, Head of Lifestyle Economics at the Institute of Economic Affairs, delivers a stark assessment: public health is recycling old fears, ignoring evidence, and steering policy into prohibitionist chaos. With governments fueling black markets and pushing vapers back to smoking, Snowdon warns the war on nicotine has only just begun.Featuring:CHRISTOPHER SNOWDONHead of Lifestyle Econ., Inst. of Economic AffairsAuthor, columnist, public health criticiea.org.uknannystateindex.org
Welcome to the Science Lab session hosted by Karin Jacobson from JTI Geneva. In this presentation, Anna Masser from Swedish Match discusses nicotine content and nicotine uptake in cigarettes and nicotine pouches, comparing their delivery methods, uptake rates, and how they are used both in clinical settings and real life.The video covers:- Differences between nicotine delivery in cigarettes vs. nicotine pouches- Standardized clinical testing protocols for nicotine uptake- Pharmacokinetic profiles and plasma nicotine concentration over time- Real-world use comparison of nicotine pouches and cigarettes- Insights into nicotine metabolism and cotinine levels- Discussion on regulated nicotine limits and product risk profiles- Audience Q&A addressing nicotine kinetics and product comparisons
GFN News speaks with Filter’s Will Godfrey about reports of dramatic increases in vaping-related emergency department visits across several US states, especially among youth, and examines what those numbers truly represent beyond the headlines. The conversation highlights how headlines like “teen ER visits surge” can obscure distinctions between acute nicotine toxicity and far more subjective “e‑cigarette dependence” admissions that have driven much of the increase in reported cases. The discussion also explores how clinicians may mark visits as vape-related simply because a patient discloses vaping, even when it’s incidental to the medical issue, potentially inflating counts without reflecting actual vaping-caused harm.
Toxicologist Autumn Bernal explains why harm reduction keeps her in the fight: reducing disease burden for adult smokers through better product design, rigorous toxicology, and clear science communication. She highlights the core engineering challenge for ENDS: optimizing heating to minimize emissions while effectively delivering nicotine—without the harmful constituents found in cigarettes. Bernal argues the U.S. currently applies the most science‑based, rigorous toxicology framework to ENDS regulation, despite its stringency.
Challenging misconceptions can save lives. Too often, outdated beliefs and misinformation prevent people from accessing safer alternatives to cigarettes. Today, Dr. Sud Patwardhan sheds light on how evidence-based strategies can help cut tobacco-related harm, especially in low- and middle-income countries where the burden of smoking is highest.
Australia’s vape prohibition is fueling a booming illicit market - while New Zealand’s regulated approach sees smoking rates fall faster. In this #GFN25 conversation, Fiona Patten speaks with Rohan Pike and Asa Saligupta about what’s broken in tobacco control, what actually works in harm reduction.
Public health’s assault on vaping and safer nicotine products isn’t guided by evidence, it’s driven by fear, outrage, and a profound misunderstanding of risk. At GFN 2025 in Warsaw, David Zaruk, the “Risk-Monger,” reveals how emotion overrides science in policymaking. From the misuse of the Precautionary Principle to the denormalization of entire industries, Zaruk argues that activist zeal and WHO dogma have turned nicotine into a moral battleground, sacrificing harm reduction and leaving millions of smokers without safer options.Featuring:DAVID ZARUKEnvironmental-Health Risk AnalystAuthor, The Risk-Monger@zarukrisk-monger.com
Explore tobacco harm reduction at GFN through a candid interview with Brazilian consumer advocate Alexandro Lucian, who shares why this global event matters, the misinformation challenges in Brazil, and why education and accurate science are essential for safer nicotine choices. Learn how language barriers, anti‑vaping narratives, and limited local research shape public opinion—and how translating complex evidence into Portuguese helps counter myths.
In this interview, tobacco harm reduction advocate Nancy Loucas unpacks how consumer voices are pushing back against vaping misinformation in New Zealand, why education matters in a “post-truth” world, and how Asia-Pacific communities win by doing it “their way".
Portugal is celebrated for its progressive drug policy, yet tobacco harm reduction remains sidelined. At GFN 2025 in Warsaw, Adriana Curado of GAT in Lisbon shows how nicotine became “the forgotten substance.” From her own move away from smoking to a pioneering vaping project with people who use drugs and those experiencing homelessness, Curado exposes public health contradictions, the persistence of stigma, and why safer nicotine options matter—especially for marginalized groups.Featuring:ADRIANA CURADOHarm Reduction Expert, Community Research OfficerGrupo de Ativistas em Tratamentos (GAT)@curadoadriana
Armenian doctor Satenik Muradyan explains why education is key to tobacco harm reduction, revealing that over 80% of physicians in Armenia lack smoking-cessation training, how misconceptions about tar vs. nicotine fuel resistance, divided youth attitudes toward safer nicotine products, and why step-by-step, evidence-based communication works—insights shared at GFN on overcoming deeply rooted misinformation.
At GFN25 in Warsaw, Paddy Costall hosts Dorrie Heemskerk and David Williams to tackle risk communication, smarter regulation without bans, and consumer-led tobacco harm reduction—from vapes and pouches to heated tobacco—amid WHO/FCTC headwinds and Europe’s tightening rules.
South Africa’s vape industry operates in a legislative vacuum, while lawmakers push a tobacco-style bill that could ban flavors and drive consumers to the illicit market. At the heart of the debate is the hostile slogan “harm is harm,” a rhetorical weapon used to erase distinctions between smoking and safer nicotine products. Shot on location at GFN 2025 in Warsaw, Asanda Gcoyi, CEO of the Vapour Products Association of South Africa, exposes how global NGOs shape local policy, the challenges of youth vaping narratives, and why recognizing relative risk is essential for the country’s smoke-free future.Featuring:ASANDA GCOYICEO, Vapour Products Association of South Africa@VPASouthAfricavpasa.org.za
Across Europe, health experts are raising alarm over the European Commission’s plan to impose new taxes on reduced-risk nicotine products such as e‑cigarettes, heated tobacco and nicotine pouches.In this episode of GFN News on GFN.TV, Joanna Junak speaks with leading international specialists — including Fernan
Panellists used their expertise in the recent regulatory developments of some key markets to shed light on broader principles. How can regulation support innovation and offer consumers choice at the same time as safeguarding public health? Do producers and consumers want the same things? Panellists discussed the risks of over- or under-regulation and the growth of illicit markets, and the discussion examined how effective regulation can drive investment, support the shift away from combustible tobacco and encourage harm reduction, also drawing lessons from other industries.
Canada’s war on nicotine has reached an extreme burden. With a 124% tax hike, sweeping flavor bans, and a “nicotine control” agenda, millions of adult vapers are in danger of being pushed back to smoking. Shot on location at GFN 2025 in Warsaw, Sam Tam, president of the Canadian Vaping Association, warns that misguided policies are destroying small businesses, fueling the black market, and undermining Canada’s smoke-free future.Featuring:SAM TAMPresident, Canadian Vaping Association@thecvaofficialthecva.org
The media often frames tobacco in a way that feels stuck in the 1990s—ignoring new science and harm reduction tools like e-cigarettes, snus, and nicotine pouches.In this interview, journalist Jacob Grier explains why coverage of smoking and tobacco policy is often outdated, how this impacts public perception, and why it’s time to rethink the conversation around nicotine.👉 What do you think—are the media behind on tobacco harm reduction? Share your thoughts below.
Join Barnaby Page (Editorial Director, ECigIntelligence & Tobacco Intelligence) as he hosts a thought-provoking discussion with Sam Tam (Canadian Vaping Association) and Jeannie Cameron (expert in international tobacco control policy).In this GFN 2025 commentary session, the panel explores:- The impact of the FCTC, 20 years later- Different perspectives on tobacco harm reduction (THR)- The evolving role of vaping and consumer advocacy- Key takeaways from the Global Forum on Nicotine so farWhether you’re a policymaker, public health professional, or simply curious about the future of nicotine, this conversation offers valuable insights into the global debate on smoking alternatives and regulation.
Institutions like WHO, regulators, and NGOs are hostile to harm reduction and have shifted their firepower from smoking to safer nicotine alternatives, says Clive Bates, international tobacco control policy expert. Shot on location at GFN 2025 in Warsaw, Bates describes public health’s “war on nicotine” as a misguided, ideological crusade that betrays its original mission of reducing smoking-related disease and death.Featuring:CLIVE BATESTobacco Control Policy Expert, Counterfactual ConsultingFormer Dir. of Action on Smoking and Health (UK)@Clive_Batesclivebates.com
Flavours have been a focal point of the debate about safer nicotine products, with calls to ban or restrict flavours often receiving significant media coverage. This workshop highlighted the growing evidence supporting the use of flavours in smoking cessation and explored changing attitudes to these products and the challenges regulators face in creating risk-proportionate legislation.
Sweden’s success with snus and now nicotine pouches proves tobacco harm reduction is a model for helping millions quit smoking. But there’s a secret behind this success. Shot on location at GFN 2025 in Warsaw, Poland, we speak with Anna Franzén and Tomas Hammargren of Emplicure about the big questions surrounding nicotine policy and the realities of recreational use.
Examining available evidence on the net public health impact of incorporating tobacco harm reduction principles in policymaking, participants discussed the challenges and opportunities to leverage tobacco harm reduction approaches to achieve LMIC public health goals. The aim was to identify the top three priorities as a takeaway for key stakeholders in the audience.
In India, hundreds of millions of tobacco users are kept in the dark about safer nicotine products, while the government bans popular alternatives like vaping and stays silent on even basic NRTs. Shot on location at GFN 2025 in Warsaw, Poland, Jagannath Sarangapani exposes how prohibition and the absence of relative risk messaging have shaped the country’s tobacco control strategy.
Achieving consensus in debates around tobacco harm reduction is rare. This workshop will explore how we can effectively build consensus in academic discussions around safer nicotine products, and correct misconceptions about tobacco harm reduction, using the Delphi Approach, a structured communications process. After short introductory remarks, participants will engage in group discussions using Delphi techniques and concepts, finishing with a Q&A and a look towards its future applications.
Flavors can play a key role in helping smokers switch. Many start with tobacco flavor but move to others over time — distancing themselves from the reminder of smoking. As adults, we enjoy sweets, drinks, and treats — why should quitting be any different?
The #GFN25 conference brought together some of the leading THR advocates from across the world, and in this episode of GFN Voices several of these prominent figures share their key gains and findings from this year's conference!
In this episode of GFN Voices we're joined by Dorrie Heemskerk to bring you some expert insight into efforts to counter misinformation in public policy.
In Sweden, the combination of snus and the emergence and uptake of pouches were likely key to its unparalleled achievement of smoke-free status, in November 2024. Despite these positive signs, regulators are circling, particularly in Europe, with bans either in force or planned in several member states. The panel will explore the science and evidence for pouches and discuss what steps need to be implemented to ensure proportionate and effective regulation.
In social media posts, official speeches, press releases and memorandums, WHO has repeatedly made claims which appear to contradict the evidence available, and which conflict with statements made by reputable public health institutions. Simply condemning the WHO’s science on tobacco harm reduction is not going to shift the dial. The panel will investigate the WHO’s science on THR, and address the organisation’s concerns, bringing objectivity and evidence to bear.
In this GFN Voices episode, advocates from across Latin America and the Spanish-speaking world joined us at #GFN25 to highlight the regional complexities that need to be overcome, and the ways the THR community is coming together to do just that.
Despite its aim to reduce global consumption of cigarettes, the impact of the WHO’s Framework Convention on Tobacco Control (FCTC) on tobacco use has been heavily contested, particularly in relation to low-income countries. The panel will assess the effectiveness of the convention as it reaches its 20th anniversary, and highlight areas that need drastic change, if it is to have any future relevance in reducing smoking.
There are more than one billion smokers in the world and the vast majority will die prematurely because of their nicotine addiction. What most people don't know is that there is a cure: vaping. Vaping is a non-toxic way to deliver the nicotine that people need without the disease-producing byproducts of burning tobacco. Compared with cigarettes, any health risks associated with vaping are very small. Yet incredibly, most tobacco control officials, public health organizations, and politicians view vaping as a threat, advocating for restrictions or outright bans. They have diverted public attention away from the benefits of vaping by greatly exaggerating the fears around youth vaping, creating unfounded concerns around nicotine, and blaming the tobacco industry for global deception. All this while neglecting cigarette smokers who have an incredible opportunity to improve their health. This anti-vaping crusade has been supported by well-funded disinformation campaigns that have left the public confused and smokers holding on to their cigarettes. Vaping must be recognized for what it is-a public health breakthrough that is urgently needed to save millions of lives.Buy book on Amazon: https://www.amazon.com/Vaping-Behind-Dr-Mark-Tyndall/dp/1834182018
GFN 2025 Keynote #3 - delivered by Maria Papaioannoy-Duic, hosted by Jagannath Sarangapani, response from Konstantinos Farsalinos.A consumer advocates’ approach, cutting through the noise to deliver factually accurate information about safer nicotine products is a constant struggle. Maria will present a ‘real-world how-to guide’, drawn from the lived experience of consumer advocates, identifying some useful tools to counter vaping and THR misinformation.
In the first episode of #GFN25 Voices, we've invited this year's in-person conference attendees to share their thoughts on the best ways to fix misperceptions about THR!
GFN 2025 Keynote #1 - delivered by Jacob Grier, hosted by Marina Murphy, response from Harry Shapiro - titled "Tobacco harm reduction and the media - evidence, narrative and consequences".Jacob will highlight how, despite positive gains made by advocates for drug harm reduction, tobacco harm reductionists face an uphill battle to be heard, let alone get the evidence across. From outdated media narratives to prohibitionist policies and their consequences, he will guide us through the current state of THR and tobacco control messaging, and help advocates create compelling narratives that share the evidence underpinning THR.
Watch Will Godfrey’s post-#GFN25 reaction, where he underscores the critical importance of effective communication in advancing the conversation around safer nicotine products. His reflections highlight how clear, evidence-based messaging can help shift public perception, inform policy, and support harm reduction efforts on a global scale.
Michael Russell Oration 2025 - "Bridging the Divide: Taking Global Action to End Smoking" | #GFN24 by GFN.TV
Tobacco harm reduction experts from across the globe recently gathered for this year's#GFN25 conference in Warsaw, so in this special series we've put together some of THR's leading experts to highlight the communication barriers that we need to overcome to share the real science behind safer nicotine products. Joining us on the conference floor today are Clive Bates, Fiona Patten and Mark Tyndall to highlight their biggest concerns facing the THR movement, and their hopes for the future.
GFN 2025 Keynote #1 - delivered by Mark Tyndall, hosted by Paddy Costall, response from Carolyn Beaumont - titled "What's so scary about tobacco harm reduction?".Mark will explore the lessons he has learned from the harm reduction movement, not least the way stigma experienced by people who use drugs, and moral judgements about drug-taking affect policy and political decision making. Consumer advocates and tobacco harm reduction campaigners face significant challenges engaging lawmakers and public health organisations, including structural opposition to safer nicotine products. How can we convince those in power that this consumer-led public health revolution can lead to real-world change?Full programme of GFN 2025: https://gfn.events/events-timeline/global-forum-on-nicotine-2025/programme/
Ahead of the upcoming World Conference on Tobacco Control, leading addiction and harm reduction specialist Garrett McGovern sat down with Brent Stafford to underscore the issues with Tobacco Control's rejection of tobacco harm reduction, and why following the science is the only rational approach to public health policy.
Poland is forging ahead with new restrictions on safer nicotine products, whilst still equating vaping with smoking - is this anti-THR messaging harming efforts to reduce smoking in the country? Przemysław Bobiński of #GFN25 media partner Vapour Poland joins us to discuss this and more!
Jacob Grier offers a sneak peek of his #GFN25 keynote on how the media misrepresents tobacco harm reduction. He unpacks the narratives driving public fear, the criminalization of safer nicotine products, and the explosive growth of the illicit vape trade. As millions turn to vaping despite the headlines, is tobacco control losing its grip on the narrative?Featuring:JACOB GRIERAuthor, Freelance WriterThe New Prohibition / The Rediscovery of Tobacco@jacobgrier
Despite rising smoking rates Mexico still heavily restricts access to safer nicotine products, leaving few options for Mexico's. But could healthcare professionals be the key to stem Mexico's smoking dilemma? Marcela Madrazo joins us to highlight this alternative approach to THR in Mexico.
Why does vape testing in laboratory conditions often differ so much from real-world use, and what are the factors affecting overheating and the creation of unintended byproducts?? Joining us again to explore the complex physics and chemistry behind vaping is nuclear physicist and vaping advocate Roberto Sussman.
For 11 years Thailand has enforced a strict prohibition of vapes, with the resulting crackdown allegedly pushing vapers towards the black market. But advocates have created a strong community opposed to this ban, emphasising the right of people who smoke to quit using safer nicotine products. To examine the intricacies of Thailand's vape ban, we're joined today by Asa Saligupta, a leading Thai vaping advocate.
Goldman Sachs predicts safer nicotine will overtake cigarettes in the U.S. this year. Millions have already made the switch, despite tobacco control efforts, not because of it. David Sweanor breaks down the consumer-led collapse of smoking and how it likely can’t be stopped.
In this episode of GFN News, Will Godfrey highlights a recent interview between Kiran Sidhu and renowned philosopher Dr. Sridhar Venkatapuram exploring the intersection of philosophy and public health, and the ethical support for tobacco harm reduction using safer nicotine products
Lindsey Stroud joins us for the second part of our USA special exploring the FDA's approach to safer products, and whether a change in approach is likely at the agency controlling the addition of new safer products to the market.
GFN News #152 | PAKISTAN'S TOBACCO CONTROL PROBLEM | Can Pakistan get on track with tobacco harm reduction? by GFN.TV
Dr. Derek Yach, a lead architect of the WHO’s global tobacco control treaty, reflects on how harm reduction was sidelined by institutional inertia, donor pressure, and deep-rooted distrust. He calls for renewed scientific dialogue, greater nicotine literacy, and an end to the moral panic that falsely equates nicotine with smoking. Despite resistance from the top, consumers are leading the charge by switching in the millions, to safer nicotine products worldwide.Featuring:DR. DEREK YACHGlobal Health Leader, Tobacco Control PolicyFmr. Cabinet Director, World Health Organization@swimdaily
Building on the strength of its popular Tobacco Harm Reduction Scholarship programme, Knowledge•Action•Change's brand new foundational course 'Understanding Tobacco Harm Reduction' is a free-to-use educational platform designed to help advocates expand their knowledge base. Joining us today to highlight this key new resource is one of its key authors, Chimwemwe Ngoma of KAC!Link to the e-course: https://thr.academy/academy/
Vaping has been shown to be 95% safer than smoking, but what do the chemistry of vapor and smoke, and the key differences between them, tell us about WHY these products are so different? Joining us again for the fourth part of our vaping science series is astrophysicist Roberto Sussman, who expertly explains the science behind vaping!
Despite the growing use of safer nicotine being strongly associated with declining smoking rates, there is still systemic opposition to these products from institutions and NGOs - but why is this the case? In this episode Lindsey Stroud joins us to unpack the FDA's reluctance to approve new nicotine products, and the misinformation used to prop up the opposition to THR.
New research reveals governments are taxing safer nicotine products like cigarettes, sabotaging tobacco harm reduction and blocking smokers from switching. Correcting these policies could accelerate global declines in smoking.Featuring:GIORGI MZHAVANADZEEconomist, K•A•Chttps://www.linkedin.com/in/mzhavanadze/
In the third episode of our science special, Roberto Sussman looks at the thermal processes that take place in vaporisation, and the impact different solvents have on the vaporisation temperature of e-liquids.
In this episode Will Godfrey highlights the interconnected links between Vietnam's recent vape ban and the influence of Bloomberg-funded entities, and how the well-funded opposition to tobacco harm reduction influences vape restrictions across the globe.
In the second part of our science special, Roberto Sussman takes us through the fundamental physics of vape aerosols to help explain the difference between cigarette smoke and e-cigarette vapor!
In 2016, PMI pledged to transition the company away from cigarette sales - and almost ten years later, they've made progress towards their promise. But instead of celebrating as 40% of PMI's business goes smoke-free, many in tobacco control would rather stand in the way. Why is that? And can anything be done to change their minds?Featuring:TOMMASO DI GIOVANNIVice President Communications & EngagementPhilip Morris International@dgtommapmiscience.com
Sweden's tobacco harm reduction success story has failed to win over Europe's politicians and regulators, with a new nicotine pouch tax rumoured to be in the works. Will the real-world impact of nicotine pouches in reducing smoking rates convince law makers to change their minds? Joining us today is Stefan Mathisson, editor-in-chief of Vejpkollen, who will walk us through the rapid rise of nicotine pouches, and the backlash brewing, in Europe.
The science of e-cigarette aerosols is complex, but is key to understanding the relative safety of safer nicotine products compared with combustible tobacco. To shed some light on the chemistry of vape aerosols, as well as how they compare tobacco smoke, we're joined today by research physicist Roberto Sussman!
Bulgaria has been embroiled in debate about a potential vape ban, including proposals to target disposable vapes. Arkadi Sarkov shines a light on the situation in Bulgaria, including the impact a disposable vape ban could have on a developing illicit market and the knock-on effect such a ban may have on vapers in the country.
What’s it like to fight for vaping in a world hostile to tobacco harm reduction? Advocate Skip Murray opens up about the soul-crushing closure of her vape shop, the rise of media scare tactics, and why she believes kindness—not outrage—is the key to saving lives.Featuring:SKIP MURRAYVolunteer Public Health AdvocateTHR Advocate, Former Vape Shop Owner@imaracingmomskipscorner.substack.com
The gateway effect is often cited by opponents of safer nicotine products as a cautionary tale about the risks of nicotine use: that young people who use nicotine are more likely to initiate smoking. However a recent study has found key evidence that indicates this is not the case. Joining us today is Will Godfrey, editor-in-chief at Filter magazine, joins us to discuss this study and its implications for nicotine research.
Could Chile's new progressive approach to safer products win over Argentina? Despite its prohibitionist stance over the past decade, Argentinian advocates are hopeful that there is room for change. To explore the divergent policies of these South American neighbours is Federico Fernández, CEO of We Are Innovation.
Chile's latest vaping bill has been met with cautious optimism from consumer advocates - but what does it actually contain? Ignacio Leiva joins us to elaborate on Chile's regulatory makeover, and what this means for vapers in the country!
Are vaping studies destined to fail? Research on e-cigarette health effects often includes former smokers—skewing results and misleading the public. Dr. Arielle Selya explores why flawed study designs, academic incentives, and NIH funding pressures shape the science on vaping and tobacco harm reduction.Featuring:DR. ARIELLE SELYABehavioural Scientist, PinneyAssociatesConsultant, CoEHAR@ArielleSelya
In the wake of a major vaping regulation overhaul in France, Claude Bamberger joins us to uncover the extent of the new disposable vape ban and where this leaves people who want to quit smoking.
In this very special episode we're joined by Jessica Harding, Programme Director of this year's Global Forum on Nicotine conference! We unpack the A-list lineup of guest speakers, plenaries and much much more that you can expect at #GFN25 which takes place 19 - 21 June 2025.
Mystery surrounds South Africa's upcoming budget announcement, with fiscal policies regarding vapes and tobacco products likely under scrutiny. But with little concrete information available, wihat could change in the coming weeks? Kurt Yeo joins us on GFN News to explore these regulatory changes and South Africa's current problematic approach to safer nicotine products.
The World Health Organization refuses to debate tobacco harm reduction, but why? In this episode of GFN Interviews, former WHO official Professor Tikki Pang exposes how the WHO’s anti-vaping stance misleads governments and fuels misinformation. He calls out the organization for cherry-picking data, ignoring real-world evidence, and prioritizing ideology over science.Featuring:PROF. TIKKI PANGFormer Director, Research, Policy & CooperationWorld Health Organization, Geneva, Switzerland
New Zealand's acceptance of safer nicotine products has spearheaded an unprecedented drop in smoking rates in its indigenous communities - can its neighbour Australia leaern a thing or two from New Zealand's success? In this latest episode of GFN News Will Godfrey joins us to highlight a recent paper by Colin Mendelsohn exploring New Zealand's plummeting smoking rates.
Belgium has become the first country in Europe to ban disposable vapes, but will this actually have an impact on youth vaping rates, or will it just reduce access to safer nicotine products for millions of adults who smoke in Belgium? Joining us today is Alberto Gómez Hernández, Policy Manager at the World Vapers' Alliance, to dissect Belgium's vaping crackdown and the impact this could have on adult vapers.
GFN News #138 | EASTERN EUROPE AND CENTRAL ASIAN SPECIAL PART TWO | Featuring Giorgi Mzhavanadze by GFN.TV
Australia’s prescription-only model continues to make legal nicotine vapes difficult to access—blocking smokers who want to quit and vapers who need to stay off cigarettes. In this episode, meet Dr. Carolyn Beaumont as she reveals the challenges, controversies, and consequences of being one of the only doctors in the world prescribing nicotine in a country at war with vaping.Featuring:DR. CAROLYN BEAUMONT, MDAustralian General Practitioner/Family Physician
Could safer products such as nicotine pouches offer a solution to significantly high rates of tobacco use in Eastern Europe and Central Asia? Joining us today is Giorgi Mzhavanadze, an economist who has worked with Knowledge-Action-Change on the Global State of Tobacco Harm Reduction report, to highlight trends in tobacco use in the region.
Mexico's smoking rates have stagnated, so why is the government insisting on amending their constitution to ban vapes? Tomás O'Gorman joins us to explain these latest developments in Mexico in this brand new episode of GFN News!
Why has New Zealand's smoking rate dropped so far below Australia's in recent years, and what can we subsequently learn from New Zealand's approach to safer nicotine products? In this episode of GFN News THR advocate Colin Mendelsohn highlights the striking difference in approach to vaping in New Zealand and Australia. Enjoy!
In Canada, youth vaping dominates the public health debate—but what about the millions of adult smokers left behind? Dr. Mark Tyndall reveals how fear, misinformation, and political convenience are obstructing access to safer nicotine products. Is Canadian public health failing its most vulnerable by rejecting harm reduction?Featuring:Professor UBC SPPH, Infectious Diseases DoctorAdvocate for Human Rights@DrMtyndall
Low nicotine cigarettes form the basis of the FDA's latest plan to reduce tobacco consumption, but will it actually work? Will Godfrey of Filter Magazine joins us to discuss the details of this proposal, and why this not-so-new idea may cause a significant headache for US smoking cessation efforts.
Germany's lawmakers have recently proposed a new ban on menthol flavours in safer nicotine products, but given that menthol is a key ingredient in over 80% of the flavours currently available on the market, could this proposed ban negatively impact the availability of safer nicotine products for people looking to quit smoking? Joining us today is Michael Landl, Director of the World Vapers' Alliance, to unpack Germany's proposals and the actions consumers are taking to make their voices heard in this debate.
GFN News #132 | CLINICAL APPLICATIONS OF NICOTINE Pt.2 | Featuring Michael Kariuki by GFN.TV
Public health’s war on vaping didn’t start with vaping—it began decades ago with secondhand smoke. The same deceptive tactics now target tobacco harm reduction. How did it begin, and where does it lead? Don’t miss this special two-part episode featuring renowned tobacco control expert Dr. Michael Siegel.Featuring:DR. MICHAEL SIEGEL, MD, MPHProf., Dept. of Public Health and Community MedicineTufts University School of Medicine@mbsiegeltobaccoanalysis.blogspot.com
GFN News #131 | TOBACCO HARM REDUCTION IN MALAWI Pt.2 | Featuring Sahan Lungu by GFN.TV
GFN News #130 | THERAPEUTIC NICOTINE EXPLAINED Pt.1 | Featuring Michael Kariuki by GFN.TV
Despite tobacco control efforts to phase out tobacco consumption around the world, a thorny issue remains - that there are many countries whose economy is fundamentally dependent on tobacco production. Amongst one of the largest producers of tobacco globally is Malawi, where tobacco makes up 60% of its exports. Sahan Lungu joins us to explore Malawi's complex relationship with tobacco in the first episode of our two part Malawi Special.
Youth smoking rates in the United States have plummeted to historic lows—an unprecedented victory in tobacco control. Yet, public health seems oddly silent. Why is this monumental achievement not being celebrated?Featuring:DR. KENNETH WARNERDean Emeritus, Prof. EmeritusSchool of Public Health, University of Michigansph.umich.edu
In the second episode of our UK Tobacco and Vape Bill special, Martin Cullip highlights the potential consequences of this latest legislation, and asks, is the UK at risk of damaging its world-leading tobacco harm reduction record?
The UK has announced a mammoth effort to combat tobacco use with its The Tobacco and Vape Bill including the eye-catching generational tobacco ban, which will prevent anyone born after 2009 from ever being able to purchase harmful combustible tobacco products. But with safer nicotine products such as heated tobacco products and snus included in this ban, will tobacco harm reduction efforts be caught in the crossfire? And can this ban even be realistically enforced? Martin Cullip joins us to discuss the generational ban on tobacco products in the UK and many more proposed regulations announced in Part One of our UK special on GFN TV!
Has the UK lost some of its THR credibility in 2024? Michelle Jones joins us to recap a year of massive change in the UK, and gives us her New Year's Wishes for 2025!
In this festive Christmas special, Liza Katsiashvili reflects on a year of impactful milestones in the tobacco harm reduction community, spotlighting key campaigns like Every Life Counts by the World Vapors Alliance and the enduring strength of advocates across the EU.
What will 2025 hold in store for consumers of safer products, and how will it compare to 2024? Lindsey Stroud and Alberto Gómez Hernandez look back on a year of highs and lows, and share their hopes and wishes for the year ahead in this episode of GFN's New Year's Wishes!
From highs, such as Sweden's standout THR success in reaching smokefree status, to lows like continued opposition and misinformation from major public health bodies, 2024 has been a year of ups and downs for THR. But underlining all this news is the resounding progress consumers are making in changing perceptions of safer products - join Will Godfrey for a full rundown of this year's news in this episode of GFN's New Year's Wishes!
Carissa Düring joins us to outline Denmark's latest restrictions targeting nicotine pouches, and highlights how Denmark's efforts compare to the tobacco harm reduction success of its neighbour Sweden.
The Mexican government is moving to enshrine a ban on nicotine vaping products into its constitution—an extraordinary overreach aimed at bypassing Mexico’s Supreme Court, which has repeatedly overturned similar bans. Critics warn this move risks driving the market underground while undermining efforts to reduce tobacco-related harm.Featuring:TOMÁS O’GORMANLawyer, Vaping AdvocateCo-founder, Pro-Vapeo Mexicoprovapeo.org.mx@vaptom
Kevin Molloy, our beloved colleague who ran the Tobacco Harm Reduction Scholarship Programme from 2018 until he passed away in 2021, helped shape and mentor a new generation of tobacco harm reduction practitioners. Joining us today are Jeffrey Zamora, a film maker and THRSP Scholar, as well as Kevin's wife Anne Molloy, and Jon Derricott, Kevin's long-standing friend, to highlight Jeffrey's new film "Love Kevin".
Harm reduction specialist Adriana Curado joins us in this episode of #GFNInsights to highlight how frontline harm reduction interventions have positively impacted marginalised communities in Portugal.
Barlinnie prison Governor Michael Stoney joins us for the first instalment of GFN Insights, a series following the exploits of THR advocates from around the globe!
Once known as the most progressive country on vaping and tobacco harm reduction, the UK is now poised to join the ranks of nations that demonize, restrict, ban, and tax, potentially lifesaving nicotine vaping products. Why is the UK turning its back on tobacco harm reduction?
Despite all the heat and dust around nicotine vapes and other safer nicotine products, consumer adoption has skyrocketed to 140 million users worldwide, as highlighted in the newly released Global State of Tobacco Harm Reduction 2024 report. Learn why tobacco harm reduction is here to stay.Featuring:HARRY SHAPIROLead Author, Executive EditorGlobal State of Tobacco Harm ReductionGSTHR.org@Shapiroharry
Switzerland is tightening up its restrictions on vaping products, bringing its policies further in line with the broader European attitude towards safer nicotine products. Joining us today is Michael Landl who provides his analysis of the latest regulatory changes and the impact they may have on vapers.
In the second part of our Czech Republic special, Filip Blaha guides us through the possible consequences of new regulations targeting psychoactive substances, and the potential for further vaping restrictions in the country. Make sure to check out our previous episode where Filip breaks down these new regulations in detail!
While the Czech Republic is introducing new measures to regulate psychoactive substances according to risk, the government is also considering harsher restrictions for safer alternatives to smoking. Filip Blaha of the Institute of Liberal Studies joins Joanna Junak to explain the proposals.
Spain's health minister recently announced a ban on disposables and flavours and advocates fear a previous proposal to ban sales online and in vape shops may also come back into play. World Vapers Alliance's Alberto Gómez Hernández gives Joanna Junak the lowdown on the proposals, explaining why advocates think it will be disastrous for public health.
The Irish government's sudden announcement of vape flavour bans, a ban on single use devices and huge tax hikes has shocked advocates. There is outrage because the public consultation had not demonstrated support for these measures. Filter's Will Godfrey reports on these policy developments and the reactions from advocates.
Tobacco harm reduction is a concept never discussed in prison, despite the toll smoking takes on inmates’ health and the lack of safer alternatives behind bars. But for those exiting the prison system, they find a new freedom in the plethora of safer nicotine options, including vaping, which offer a path to better health and control over their finances and well-being. Featuring:DR. CHRISTY PEREZJournalist, Theologian (aka C. Dreams)Contributing Writer, Filter@UnCagedCritiquefiltermag.org
Sweden's government now recognises that reduced risk nicotine products are key to the country's low smoking prevalence. A new risk proportionate tobacco policy is being devised, but there is opposition. Will tobacco harm reduction be fully integrated into Swedish legislation? Stefan Matthison fills us in on the current state of play.
Canada's Minister for Health wants to ban nicotine pouches but how easy will it be to shut down the booming black market? In Part 2 of our Canada special, Maria Pappaioannoy talks to Joanna Junak about the difficulties THR advocates are facing in Canada, and why Rights for Vapers now advocates for all safer alternatives to smoking.
Whilst Canada's looming flavour ban may have been postponed, various provinces and the Minister for Health have taken action to prevent the sale of flavoured nicotine products. Joining us today is Maria Papaioannoy to highlight the adverse impact these prospective bans may have on marginalized communities in Canada, and the broader implications these actions could have on the right to health.
It’s a move that has left nicotine pouch users scrambling. In late August, Canadian Health Minister Mark Holland followed through on his March threat to severely limit the availability of nicotine pouches, citing the need to protect youth. The new restrictions ban the sale of nicotine pouches at all retail locations, allowing access only behind the pharmacy counter. As a result, thousands are now without access to this critical safer nicotine product.Featuring:FRANK PARKERPublic Affairs ConsultantTobacco Harm Reduction Advocate
Despite a total ban on vapes in Brazil, even the authorities are confused about the precise regulations prohibiting vapes. Meanwhile consumers fight for regulation that will combat the risk of contraband vapes in the country. Joining us today is Alexandro Lucian, a journalist, specialist researcher in THR and president of Direta, a non-governmental consumers organisation focused on tobacco harm reduction, to bring us all the latest updates from Brazil!
New Zealand takes another step in its smokefree journey with its latest vaping proposals, but how will New Zealand's last minute change to these vaping restrictions impact people looking to quit smoking in the country, and will these new measures have a real-world impact on youth vaping? Joining us is Nancy Loucas who will guide us through New Zealand's latest efforts to combat youth vaping.
Medical doctor and addictions specialist Garrett McGovern warns that most people in his profession who are anti-vaping seem to want electronic cigarettes to be “more harmful” than they are and it's almost as if “they don't want them to be safe or safer.”Featuring:DR. GARRETT MCGOVERNMedical Director, Priority Medical Clinic DublinGP Specialising in Addiction Medicine@AddictionsPMC
Glimmers of good news despite the general drift towards harsher restrictions for tobacco harm reduction.
New legislation in Australia means that vapes can only be bought in pharmacies, with e-liquid only available in three flavours. What are the likely consequences of this, in a country where the black market for vaping products is already booming?
Science is an enabler at Japan Tobacco International, driving innovation in risk-reduced tobacco products and reinforcing its position when responding to critics. 'Each scientific study is a piece of the puzzle,' says Ian Jones, V.P. of the Scientific Product Assessment Center at JTI.Featuring:IAN JONESV.P., Scientific Product Assessment CenterJapan Tobacco Internationaljti.com
In today's GFN Voices, Kurt Yeo explores the crucial relationship between economics, health, and tobacco harm reduction. With a focus on South Africa, he delves into the burden tobacco places on public health, the economic challenges it creates, and how harm reduction strategies could be the key to a healthier future.
In this insightful discussion, Liza Katsiashvili, Andrzej Fal and Ethan Nadelmann tackle the growing misconceptions surrounding vaping and tobacco harm reduction. Learn how misinformation, fueled by media and powerful institutions like the WHO, is shaping public opinion and preventing effective harm reduction strategies.
Spreading misinformation about nicotine vaping to vulnerable populations leads to dire consequences, warns Kiran Sidhu, a leading THR writer-journalist for Filter.Featuring:KIRAN SIDHUWriter-Journalist, FilterTobacco Harm Reduction Fellowfiltermag.org@KiranSidhu41
This workshop will explore the horizontal relationship of physicians, consumer advocates, and regulators to promote science-based communication and harm reduction alternatives to advance public health.GFN 2024 Workshop - hosted by Jeffrey Zamora and Carmen Escrig with panellists: Jorge Palma, Diego Verrastro, Tomás O'Gorman, Fernando BuenoFull programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/
In this video, we dive into the highlights and key takeaways from a recent global advocacy conference. Hear from Michael Landl as he shares his favorite sessions, including an inspiring talk by Ethan Nadelmann. Learn about the importance of community, shared experiences, and effective strategies across different countries.Featuring Michael Landl, Jarkyn Shadymanova and Pranay Ratna Sakya.Full programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/
For Tobacco Harm Reduction (THR) to become widespread, affordable and appealing, reduced-risk alternatives to harmful tobacco products must be legally available and accessible. Achieving this requires sustained, substantial investment. The pace of harm reduction is closely tied to investment levels, influenced by potential risks and returns. Regulatory risk and uncertainty increase the returns required by investors, reducing available capital. Consequently:- Reduced Investment in Product Development: Lower investment hinders the development of safer and more appealing products supported by scientific research. Without this, regulators are unlikely to consider them as effective harm-reduction solutions, and existing RRPs do not appeal to most smokers.- Limited Accessibility in the Global South: Insufficient investment in cost reduction makes these products inaccessible to consumers in the Global South, home to 80% of harmful tobacco users.- Hesitancy to Enter High-Risk Markets: Companies and investors are less likely to enter markets with high regulatory risk.GFN 2024 Workshop - hosted by Pieter Vorster with panellists: Sud Patwardhan, Jonathan Fell and Marina Murphy
Supporting tobacco harm reduction is more than just pragmatic positioning to appease financial analysts and stakeholders. For Imperial Brands, one of the world’s major tobacco companies, THR represents a consumer-focused commitment to helping individuals switch to less harmful forms of tobacco. It's a strategy that balances both head and heart, reflecting a thoughtful approach to the future of safer nicotine products.Featuring:Joe ThompsonGroup Science & Regulatory Affairs Director, Imperial Brands
We delve into the key insights and discussions from the Global Forum on Nicotine (GFN). Our expert speakers share their experiences and reflections on the evolution of tobacco harm reduction, exploring the intersection of science, economics, and politics. Learn about the challenges faced, the progress made, and the future of tobacco harm reduction in public health.
Tragically, those who should know better—medical doctors, public health officials, and the media—are reluctant to promote nicotine vaping as a tool for harm reduction. Instead, they make a deliberate choice to ignore or avoid acknowledging the truth about vaping. This problem is widespread, including in Latin America. Learn more in this special hybrid English/Spanish episode of GFN Interviews.Featuring:DR. DIEGO VERRASTROPhysician, General and Emergency SurgeryCo-founder, Latin American Network for THR, RELDAT.orgJEFFREY ZAMORAPresident, Asovape Costa Rica & of ARDT IberoamericaDirector of Social Media, INNCO@jeffzam8
We all have to have a voice in this discussion! | GFN24 Commentary Team hosted by Sarah Cooney by GFN.TV
An examination of the nature of the THR debate, including different factions' objectives and the tactics being used, such as misinformation, emotive appeals and personal attacks. Panellists will share their own experiences, discuss why the debate is being conducted as it is, and ask how we should best operate in a challenging and often hostile environment.GFN 2024 Panel Discussion #4 - hosted by Will Godfrey with panellists: Marewa Glover, Rohan Sequeira, Maria Papaioannoy-Duic, Christopher Snowdon
Join host Rebecca Taylor, a health policy specialist and former member of the European Parliament, as she leads an insightful discussion on the recent European election results and their implications for tobacco harm reduction, featuring: - Michael Landl - Director of the World Vapers Alliance from Austria;- Konstantinos Farsalinos - Physician and public health researcher from Greece;- Fernando Fernandez Bueno - Oncology surgeon and tobacco harm reduction advocate from Spain.
Despite considerable scientific evidence to support the efficacy - and relative safety - of safer nicotine products (SNPs) powerful voices continue to place obstacles in the way of consumers. Consumers are an often neglected voice in the debates that often result in disproportionate regulation, restrictions on sales and use and outright bans applied to SNPs. There are some notable exceptions, where consumers have had their voices heard and garnered support from legislators, resulting in a more balance and nuanced approach.This session will attempt to ’take stock’ of where we are and what the next steps might look like, and will be consumer lead, with panellists from different regions reflecting on how the debate has been conducted and what influence they may have been able to bring to bear. What are the challenges and what strategies can have a positive impact? How can the science supporting SNPs be effectively promoted and how can the consumer experience be incorporated - ’nothing about us without us’? Who are the key actors and how might they be engaged in a constructive way? What can most effectively assist consumer advocacy to succeed?GFN 2024 Workshop - hosted by Tom Gleeson with panellists: Ignacio Leiva, Carissa Düring and Asa Saligupta.Full programme of GFN 2024: https://gfn.events/events-timeline/global-forum-on-nicotine-2024/programme/
WHAT’S WRONG WITH THE COMMONWEALTH? | GFN24 Commentary Team hosted by Brent Stafford by GFN.TV
The hosts, together with a panel representing scientists, consumers and other stakeholders will review a selection of scientific papers, published in the past 12 months, on nicotine and THR-related issues, identifying the best and worst examples.GFN 2024 Panel Discussion #3 - hosted by Clive Bates with panellists: Arielle Selya, Gizelle Baker and Roberto Sussman.
Philip Morris International is at the centre of the battle over the coming smoke-free world, having spent billions transitioning to reduced-risk products like oral tobacco, heated tobacco products, and vaping. Yet they are still one of the largest producers of combustible tobacco products. How is the journey to the smoke free future going? Featuring:Ondrej KoumalDirector External Affairs, Philip Morris Internationalpmiscience.com
An examination of the health and economic impact of tobacco control measures and the role for proportionate regulation and risk management for alternative nicotine products.GFN 2024 Panel Discussion #2 - hosted by Clive Bates with panellists: David Sweanor, Nevena Crljenko, Konstantinos Farsalinos and Joe Thompson
Australia intensified its war on vaping with new, punitive regulations that will criminalize nicotine vaping products to an extent unseen in the Western world. The government explicitly states that its goal is to 'reverse the increasing uptake of recreational nicotine.Featuring:Prof., Dr. Sharifa Ezat Wan PutehPhysician, Prof. Public Health, National University of MalaysiaChairman of the Malaysia Society of Harm Reduction
Tobacco harm reduction market influence - past, present and future - Keynote #3 | #GFN24 by GFN.TV
Misinterpretation of the precautionary principle in relation to safer nicotine - Keynote #2 | #GFN24 by GFN.TV
2024 Michael Russell Oration - delivered by Cliff Douglas - President and Chief Executive Officer of the Global Action to End Smoking - titled "Bridging the Divide: Taking Global Action to End Smoking"
What’s holding up the transformation to safer nicotine products in low-income and middle-income countries, known as LMICs? In India, there are over 300 million tobacco users, with many using what Dr. Sudhanshu Patwardhan calls “risky forms of tobacco” that significantly increase cancer severity. Hear Dr. Sud’s “bottom of the pyramid” plan to supercharge the tobacco transformation in LMICs.Featuring:Dr. Sudhanshu PatwardhanMedical Doctor, Nicotine Expert@Doctor_Sud
Australia intensified its war on vaping with new, punitive regulations that will criminalize nicotine vaping products to an extent unseen in the Western world. The government explicitly states that its goal is to 'reverse the increasing uptake of recreational nicotine.Featuring:Fiona PattenFormer Member, Parliament of Victoria, AustraliaChair, Australian Consumers’ AssociationHarm Reduction, Vaping Activist@FionaHPatten
Under Spain's new anti-smoking plan, safer nicotine products will now be equated with smoking in the latest measures to restrict vaping in the country. Joining us today is Carmen Escrig, Coordinator of the Spanish Medical Platform for Tobacco Harm Reduction, who will highlight the pushback against this proposal and the institutional biases that helped create it in the first place.
When India's government added nicotine replacement therapies to its list of essential medicines, tobacco harm reduction advocates celebrated a win for smokers looking to quit. But was this success short lived, and has India returned to an anti-nicotine frame of mind? Joining us today to discuss India's track record with nicotine is journalist Samrat Chowdhery.Link to the arcticle: https://tobaccoreporter.com/2024/05/01/a-perfect-storm/
In today's episode Will Godfrey joins us to bring us the latest updates from the E-Cigarette Summit in Washington DC, USA, where the FDA stirred up controversy and the real impact of restrictive vaping policies was laid bare!
Despite suffering years of pernicious misinformation and an onslaught of regulation leading to product restrictions and bans, in many countries, the popularity of nicotine vaping continues unbridled growth. Indeed, according to Barnaby Page, editorial director at Tamarind Intelligence, it’s unstoppable!Featuring:Barnaby PageEditorial Director, Tamarind Intelligenceecigintelligence.com
In today's episode Gabriel Oke, a public health professional and researcher, puts a spotlight on the use of social media to disseminate misinformation during the EVALI scare and COVID-19 pandemic, and how advocates and policy makers are having to adapt to a new world of instant communication.
Australia has taken a hardline approach to vaping leaving smokers wanting to quit with few legal routes to access safer nicotine products. In today's episode leading Australian THR advocate Colin Mendelsohn asks, have these restrictions actually achieved their intended goals? In his recent evidence to Australian Senators, Colin set out how a compassionate approach could be the key to improving Australia's vaping situation.
In today's episode GFN Interviews host Brent Stafford swapped his usual interviewer's seat to join Joanna Junak to discuss all things #GFN24, the current global backlash to tobacco harm reduction from tobacco control proponents, and what he's learned since beginning to cover the world of tobacco harm reduction with Regulator Watch.
Tobacco policy in New Zealand could leave one with a touch of motion sickness as the country lurches back and forth in its effort to reduce smoking to five percent by 2025. Researcher Marewa Glover joins GFN Interviews to discuss the latest surprising shift and results of her new study on how New Zealand adults who smoke understand novel tobacco ‘endgame’ policies.Featuring:Dr. Marewa GloverDirector, Centre of Research ExcellenceIndigenous Sovereignty & Smoking, New Zealand@MarewaGlover
Colin Mendelsohn, a veteran Australian tobacco harm reduction advocate, recently had the opportunity to educate lawmakers about the science underpinning vaping, the moral panic surrounding nicotine and the consequences of Australia's prohibitionist stance on vaping. In this episode we have collected a series of powerful points that Colin made in his discussion with lawmakers.
Colombia has recently introduced new vaping regulations which have effectively equated vapes with tobacco products. In the name of reducing youth access to vapes, have the government sidelined smokers in the process? Joining us to explore this in today's episode is Francisco Ordoñez, founder and president of Asovape Colombia.
Slovenia has recently enacted a flavour ban that has further cemented its hardening attitude to vaping, but have consumers' voices been ignored throughout these considerations? Joining us today is Liza Katsiashvili of the World Vapers' Alliance to discuss the impact of FCTC and WHO directives on vaping regulations around Europe, and the consumer reaction to Slovenia's flavour ban.
Cliff Douglas is, as they say, the “real deal”. An essential attorney in the tobacco wars of the 1990s, an adviser to the U.S. FDA and Surgeon General and vice president of tobacco control at the American Cancer Society. He is a tobacco control veteran and now the leader of a global organization dedicated to reducing tobacco harm through harm reduction.Featuring:Clifford E. DouglasPresident & C.E.O., Foundation for a Smoke-Free WorldFormer VP, Tobacco Control, American Cancer Societysmokefreeworld.org@cdoug
The WHO has recently stirred controversy by sharing widely criticised claims about vaping on its social media accounts, so in today's episode of GFN News we ask, what's this all about? And has this happened before? Joining us today is Will Godfrey who filled us in on the latest chapter of the WHO's infodemic problem.
Nicotine pouches such as Zonnic and Zyn have taken many countries by storm, but in Australia heavy handed restrictions on nicotine have limited legal access to pouches. In today's episode, Colin Mendelsohn updates us on the rise of nicotine pouches in Australia, and the science supporting the claim that they are safer than smoking.
In today's episode of GFN News Chris Baxter shares his own views on the addictive nature of nicotine and the current state of nicotine research, and reflects on his GFN Five submission from GFN22 covering the addictiveness of nicotine.
Actions by anti-tobacco harm reduction advocates and organizations are “outrageous” and “disgusting,” says Ethan Nadelmann, legendary drugs harm reduction campaigner. Why are the lessons learned in the fight to end the war on drugs ignored in the battle to end the war on vaping?Featuring:Ethan NadelmannFounder & Former Executive Director, Drug Policy AlliancePodcast Host, PSYCHOACTIVE@ethannadelmann
Dive into a world of impactful insights as we unpack the most compelling takeawys from the first quarter of 2024 GFN News!
Mexico's President is seeking to solidify Mexico's hardline approach to vaping with a proposal to ban vaping through a constitutional amendment, to the consternation of vaping advocates who fear smokers will lose access to these safer alternatives in the country. Joining us to today is Tomás O'Gorman, co-founder of "Pro-Vapeo Mexico" and a member of INNCO’s Board, who highlights the hardening of Mexico's anti-vaping stance and the impact this could have on smokers' ability to quit in Mexico.
The rising popularity of nicotine pouches in the United States, in particular Zyn, has been met with backlash and misinformation, despite the proven efficacy of safer nicotine products in helping smokers quit. In today's episode we're joined by Martin Cullip of the Taxpayers Protection Alliance.who takes a closer look at the motivations behind this backlash and the actual evidence at stake.
Despite extensive regulatory barriers and massive misinformation on relative risk, consumers are transitioning from cigarettes to safer nicotine products at an extraordinary pace. In today’s episode tobacco control policy expert David Sweanor guides us through the remarkable growth of the U.S. vaping market and issues a warning to those who seek to stand in the way.Featuring:David SweanorAdj. Professor, Faculty of Law, University of OttawaTobacco Control Policy Expert@ottawaharmredux
The European Union is currently deliberating its regulatory approach to safer nicotine products as it reviews its Tobacco Products Directive. In a bid to ensure consumer voices are not lost amongst these discussions, the World Vapers' Alliance is bringing a petition before the European Parliament to reaffirm the need for proportionate regulation of safer products. In this episode of GFN News, the WVA's Director Michael Landl fills us in on these efforts to boost the consumer voice in Europe.
Despite the overwhelming evidence indicating that safer nicotine products are significantly less harmful than smoking, vaping misinformation has stoked mistrust of safer products, most notably seen in fears surrounding EVALI and youth vaping. In this episode, Will Godfrey looks at a recent study tracking the decreasing trust in vapes amongst the general public, and the real-world consequences that vaping misinformation has on public health.
Zonnic pouches entered Canada with a bang in 2023 after they were approved as a smoking cessation aid, leading to their widespread availability throughout Canada. To explore why Zonnic has become so controversial, John Oyston joins us for this episode of GFN News where we dissect Zonnic's Canadian debut and the resultant response from Public Health institutions to this novel safer nicotine product.
The UK’s ban on disposable nicotine vapes demonstrates the many misbeliefs surrounding the “gateway” theory are thriving. But isn’t the theory that youth e-cig use is a gateway to smoking de-bunked? According to Dr. Arielle Selya it is and there’s no room for doubt.Featuring:Dr. Arielle SelyaBehavioural Scientist, PinneyAssociates@ArielleSelya
GFN24 will be hosting its very own film festival, showcasing the best short films from the GFN community exploring the vital role of tobacco harm reduction in the public health sphere. Multi-award-winning film maker Emmanuel Mwape joins us to tell us all about the GFN Film Festival, and what we have to look forward to live at #GFN24 in Warsaw!
Following New Zealand's latest overhaul of its vaping regulations and its U-Turn on its Generational Smoking ban, we talk with Jan Walsh and Nancy Loucas for a closer look at New Zealand's aim to be Smokefree by 2025 in this episode of GFN News!
Poland could soon join the growing list of countries that have chosen to enact disposable vape bans, as the Polish government announces its intention to crack down on vaping in the country. To explore this ban proposal, and its likely efficacy, we're joined today by chemist and vaping advocate Mirek Dworniczak.
THR advocates and researchers continue to analyse the fallout from #FCTCOP10, and its implications for millions of users of safer products around the globe. In this special episode of GFN News, Brent Stafford of Regulator Watch asked leading THR experts at the Good COP / Bad COP event in Panama for their response to the events of #FCTCCOP10.
Despite resounding criticism of COP10 from consumers, THR advocates and healthcare professionals, the WHO has applauded its own efforts to promote prohibitionist policies. In this episode Will Godfrey (Filter Magazine) recaps the proceedings of COP10 in Panama, featuring member state rebellions and fight back from consumers and advocates - you don't want to miss this!
In recent weeks the UK has announced a total ban on disposable vapes, with consternation and celebration from a broad range of stakeholders, experts and the general public - but will the government stop there? In this episode Michelle Jones (Editor of Ecigclick) deconstructs the factors influencing the government's proposal, and looks at the further restrictions on safer products that could be introduced.
With an estimated 7 million smokers out of a population of 19 million, the Eastern European country of Romania has a lot of work to do to help its citizens quit the deadly habit. Instead, Romania plans to enact a new excise tax that would double the cost of safer nicotine products, like vaping.Featuring:Alex GogoanaPresident, ACPANConsumer Assoc. of Nicotine Products, Romaniaacpan.ro
The UK's recent unveiling of a total ban on disposable vapes, and additional flavour restrictions, risks undoing the nation's pioneering tobacco harm reduction approach to reducing smoking. Clive Bates joins us in today's episode as we look at the potentially disasterous consequences of a disposable vape ban, as well as the convenient timing of this announcement to coincide with the start of the FCTC COP10 in Panama.
With COP10 due to take place next week, and with consumers denied a seat at the table, Lindsey Stroud walked us through how consumers are making their voice heard at the Good COP / Bad COP event, which will be livestreamed from COP10 in Panama!
Indonesia's recent changes to e-cigarette taxation, which now place e-cigarettes in the same category as combustible tobacco products, have caused uproar amongst retailers and consumers. Garindra Kartasasmita joins us to explain these latest developments, and why the government is dead-set on denying vaping science.
What happens when ideology meets science? Look at the debate over nicotine vaping products for the answer. Just a decade ago tobacco control made great strides towards eliminating cigarette smoking. But in a bizarre effort to undermine nicotine vapes, public health is now contorting science and pushing people back to smoking.
In a landmark ruling the FDA's refusal to authorize new non-tobacco flavoured vaping products has been sharply criticized. We ask Will Godfrey of Filter Magazine if this could be a turning point for flavoured products in the United States, and how the FDA will now seek to reassert its authority in the aftermath.
A vaping literacy problem may lie at the heart of India's hardline approach to vaping. Could improved tobacco harm reduction education amongst medical professionals and policy makers help shift India away from the WHO's prohibitionist anti-vaping stance? Samrat Chowdhery joins us to discuss this and more!
Consumers recently took the fight for safer products to the European Parliament with their contributions to an event titled “Harm Reduction: The Road to a Smoke Free Europe." Tom Gleeson of NNA joins us to analyse the arguments brought by consumers to MEPs at this event, and whether this means attitudes to THR could be changing in Europe.
Where’s the parade for all the people who quit smoking thanks to nicotine vapes? This is the question Janine Timmons wants tobacco control bureaucrats to answer when they gather next month in Panama for the World health Organization’s COP10 conference. She’s afraid attendees will continue to dig for the worst possible excuse to ban vaping, when they should be celebrating its success in helping smokers to quit.Featuring:JANINE TIMMONSConsumer, Nicotine Vaping Products@grayjaynine
France is set to ban disposable vapes in an effort to combat environmental waste and potential gateway risks - but do these fears add up? Claude Bamberger joins us to discuss these latest policy changes and the reality of disposable vape use in France.
GFN's NEW YEAR WISHES #10 | AUSTRALIA'S NICOTINE HEADACHE | With Carolyn Beaumont by GFN.TV
GFN's NEW YEAR WISHES #9 | LATAM FIGHT FOR SAFER PRODUCTS | With Ignacio Leiva and Alexandro Lucian by GFN.TV
GFN's NEW YEAR WISHES #7 | IS OPPOSITION TO THR FINISHED? | With Roberto Sussman by GFN.TV
GFN's NEW YEAR WISHES #5 | 2024: WILL REGULATORS LISTEN TO THE EVIDENCE? | With Tomás O'Gorman by GFN.TV
GFN's NEW YEAR WISHES #4 | SWEDEN'S 2023 TRACK RECORD | With Carissa Düring and Stefan Mathisson by GFN.TV
GFN's NEW YEAR WISHES #3 | REASONS FOR OPTIMISM IN 2024 | With Martin Cullip and Michelle Minton by GFN.TV
GFN's NEW YEAR WISHES #2 | A YEAR FOR CHANGE | With Allison Boughner and Maria Papaioannoy by GFN.TV
GFN's NEW YEAR WISHES #1 | THE ENDGAME FOR SMOKING? | With Paddy Costall and Jessica Harding by GFN.TV
Chile's upcoming vaping legislation sets the bar high for neighbouring countries - with significant gains made by THR advocates, what does this mean for Chilean vapers?
2023 has been another dramatic and turbulent year for vapers and smokers across the globe. Whilst there have been draconian clamp downs on safer products, and vaping misinformation remains rife, there have also been notable positive developments. In today's episode Will Godfrey joins us to summarise the most significant THR news stories covered by Filter Magazine in 2023.
Mexico’s ban on nicotine vaping leaves consumers caught in the crossfire. While the “tobacco wars” narrative is obsolete, it continues to cause damage, says physicist and tobacco harm reduction advocate Dr. Roberto Sussman. While the tobacco industry today is no longer the villain it once was, public health campaigners continue to wage war, striking disruptive technologies like nicotine vapes that provide safe and effective alternatives to combustible tobacco.
With sweeping vaping age-restrictions now in force in Ireland, and flavours and disposables in the spotlight, we ask Garrett McGovern if these new and potential restrictions will negatively impact Ireland's ongoing goal to reduce smoking rates.
In part two of our Brazil special, Alexandro Lucian walks us through the mayhem of black market vaping sales in Brazil amidst calls for reform of the blanket vaping ban currently in place.
Brazilian tobacco harm reduction (THR) activists face an uphill battle against the combined efforts of vaping bans, well funded anti-THR messaging and nicotine misinformation. In today's episode, we're joined by Alexandro Lucian to find out if there's a way forward for THR in Brazil.
A spike in U.S. youth vaping rates back in 2018 sparked a worldwide moral panic over teen vaping. But the so-called “epidemic” was short-lived. In just 4-years, U.S. teen vaping fell over 60% to a historic low in 2023. It’s good news for everyone except those campaigners who profit from panic.Featuring:MICHELLE MINTONSenior Analyst, Reason Foundationreason.org@michelleminton
Meet Diego Verrastro from Argentina and Julio Ruades from Spain, who share their perspective on #GFN23.
A UK government consultation on e-cigarette restrictions is due to conclude on 6 December 2023, with restrictions on flavours and disposable vapes amongst the proposed regulatory changes. In this episode James Dunworth, chairman of E-Cigarette Direct, joins us to discuss this consultation, and the opportunity it provides for vapers to make their voices heard.
Three leading tobacco harm reduction experts join us to give their predictions, hopes and fears for the Tenth Conference of the Parties of the FCTC, which was due to take place on 20 November 2023 before being postponed at the eleventh hour.
Canadian tobacco harm reduction advocate and nicotine vape retailer takes a stand against anti-vaping critics at home while preparing to take on the WHO at the upcoming FCTC COP10, the Conference of the Parties in Panama, this November.Featuring:MARIA PAPAIOANNOY-DUICVaping Activist, Canada@papaioannoy
Will Godfrey joins us in today's episode to explain a proposed menthol cigarette ban in the United States, and the legal obstacles preventing flavoured vaping products from launching in the United States.
The evidence is clear: vaping is far safer than smoking, and vaping is a much more effective quitting aid than traditional nicotine replacement therapies. But many regulators and key stakeholders remain unconvinced. In this episode, Colin Mendelsohn discusses his recent review exploring the evidence behind vaping and the way forward for nicotine in Australia.Read the report here: https://colinmendelsohn.com.au/report-2/
In November the Tenth Conference of the Parties (#COP10) to the Framework Convention on Tobacco Control (FCTC) will meet in Panama, with the fate of safer nicotine products hanging in the balance. Harry Shapiro joins us to shed some light on these closed-door proceedings, and how these meetings will inevitably impact tobacco harm reduction efforts around the globe.Read the GSTHR #COP10 Briefing Paper here: https://gsthr.org/resources/briefing-papers/the-fctc-cop10-agenda-and-supporting-documents/
While the United States of America is ground zero for the anti-vaping propaganda and misinformation that poisoned worldwide public perception of vaping, it’s also home to a solid and relentless vaping advocacy community pushing back against the anti-vaping hordes. How are they doing? Find out in this episode of GFN Interviews.Featuring:Allison BoughnerVice President, American Vapor ManufacturersMarketing & Communications Director, ECIG Charleston@alli_vapes@vapouramericanecigcharleston.com
Nicotine pouches have enabled Sweden to reach "smoke-free" status, and have shown how safer nicotine products could help reduce the global health burden associated with smoking and high-risk tobacco products. In this episode, Carissa Düring discusses the rise of nicotine pouches and how the Swedish approach could serve as a model for the rest of the world.
GFN Voices with Carmen Escrig, Samrat Chowdhery and many more famous faces from #GFN23 by GFN.TV
There is a particular piece of information you are not supposed to talk about. You certainly can't promote it. And never depend on public health to acknowledge it. What is it? Nicotine is not carcinogenic; when consumed outside of a cigarette, it is benign. Likely no more harmful than caffeine. According to harm reduction consultant and developmental neurobiologist Charles Gardner, nicotine could have significant health benefits.Featuring:CHARLES A. GARDNER, PhDConsultant, Harm Reduction StrategiesDevelopmental Neurobiologist@ChaunceyGardner
In this episode Chimwemwe Ngoma, a leading tobacco harm reduction advocate from Malawi, discusses a recent study examining attitudes to THR in African online news media, and how a lack of consensus amongst global public health authorities stokes confusion amongst smokers and users of safer products.Click here to read the study discussed in today's episode:
In this episode of GFN News, Pritika Kumar discusses a recent study looking at how THR and safer products are viewed by frontline health and social care workers, and how a revolution in THR training amongst frontline professionals could be a crucial step in reducing smoking rates in at-risk groups.
There is too much emotion driving public policy on e-cigarettes, says leading tobacco control researcher Dr. Jasjit Ahluwalia. A physician, public health scientist, and professor at Brown University’s Schools of Public Health and Medicine, Dr. Ahluwalia has deep experience researching health disparities and smoking cessation and nicotine addiction in African-American smokers. He has been continuously funded by the NIH for 25 years and has published over 400 manuscripts. Hear his assessment on the efficacy and relative safety of e-cigarettes and other safer nicotine products.Featuring:DR. Jasjit AhluwaliaPhysician, Public Health ScientistProf. Behavioral and Social Sciences & Internal Medicine Center for Alcohol & Addiction StudiesBrown University School of Public Health@Brown_SPH
GFN News #69 | FRENCH DISPOSABLE VAPE BAN ON HORIZON | Will Godfrey reacts to the latest THR news by GFN.TV
Tobacco control has no sympathy for the smoker, says Samrat Chowdhery tobacco harm reduction expert and consumer activist. He says there has to be a more humane way to tackle the tobacco problem and tobacco control needs to start thinking more like drugs control.Featuring:SAMRAT CHOWDHERYJournalist, THR Consumer Activist@SamratTHR
Kickstarting a brand-new season of GFN News on GFN•TV, Martin Cullip and Joanna Junak review the latest vaping prevalence data from the UK and the "patronising" responses to these figures from the UK media.
Join us for the sixteenth episode of GFN Voices 2023! Today, we interviewed Tomas O'Gorman on the importance of consumers in Tobacco Harm Reduction and Norbert Zillatron Schmidt, who spoke on the current perception of nicotine.
Tobacco harm reduction activist and award-winning African filmmaker discusses unheard narratives around safer nicotine products, smoking cessation, and tobacco control.Featuring:Emmanuel MwapeAward Winning Filmmaker, THR ActivistK•A•C Global THR Scholar, Zambia@mwape_emmanuel
Editor and co-founder of Drink and Drugs News discusses the difficulties of tackling smoking and how many people working in the drug harm reduction field don’t see it as a problem.
Featuring: Claire Brown Editor & Co-founder, Drink and Drugs News Magazine drinkanddrugsnews.com @DDNMagazine
Join us for the ninth episode of GFN Voices 2023!
In this episode, Jeffrey Zamora and Francisco Ordoñez reflect on the Latin American focus of #GFN23. You can rewatch both Spanish language sessions from #GFN23 at GFN Youtube Channel!
There’s no debate allowed on vaping in Australia, says Dr. Colin Mendelsohn, founding chairman of the Australian Tobacco Harm Reduction Association and practicing tobacco treatment specialist. Tobacco control is “impervious to evidence” and quick to cancel anyone who speaks to the positives of vaping.
Featuring: DR. COLIN MENDELSOHN Founding Chairman Australian Tobacco Harm Reduction Association Practising Tobacco Treatment Specialist @colinmendelsohn
Professor Gerry Stimson, public health social scientist and co-founder of the Global Forum on Nicotine receives the 2023 Michael Russell Award in recognition of a lifetime’s commitment to evidence-based public health interventions. Hear his reaction to the award and thoughts about what’s coming next for GFN and tobacco harm reduction.
Featuring: Gerry Stimson Co-founder, Global Forum on Nicotine Director, Knowledge-Action-Change (KAC) Emeritus Professor, Imperial College London @GFNicotine
Hear how science drives the development of reduced-risk nicotine products at BAT, one of the world’s largest tobacco companies. And learn how it uses science to help ‘seal the deal’ with regulators.
Featuring: DR. SUMMER HANNA VP Scientific Regulatory Engagement, BAT bat-science.com
Hear how a once skeptical drug policy advocate became convinced about the power of nicotine vapes to help make positive changes in the lives of the vulnerable.
Join us for the first episode of GFN Voices 2023!
GFN23 brought together some of the best researchers, organisers and activists in the tobacco harm reduction world, and over the next few weeks we will be sharing their insights about the last 10 years of GFN, and what they think next decade of THR may look like.
To start off, Alex Wodak gives us his thoughts and favourite highlights from the GFN23 conference in Warsaw, and how global outlooks on THR contrast with stark vaping restrictions in Australia.
GFN.TV Interviews | ‘PATIENT’ CONTROL | Clive Bates Previews GFN 2023 & The Big THR Conversation by GFN.TV
The FDA has proposed a cap on cigarette nicotine content - will this drive smokers to safer products, or towards unregulated alternatives? Will Godfrey discusses the uncertain future that lies in the hands of the FDA.
John Oyston brings us tan update on Canada's latest youth vaping statistics, and the impact flavour bans could have on smoking rates.
With Sweden close to becoming smoke-free, Federico Fernández discusses a recent survey of ex-smokers conducted by We Are Innovation.
Although vital to shaping appropriate public health responses, the current data describing trends in the use of nicotine products are not ideal, and may provide an incomplete picture of nicotine habits. In today's episode, Tomasz Jerzyński talks nicotine-use data: how do we collect it, how do we analyse it, and how do we use it?
GFN News #63 | WILL AUSTRALIA'S PRESCRIPTION-ONLY MODEL SUCCEED? | Featuring Will Godfrey by GFN.TV
GFN News #62 | QUEBEC FLAVOUR BAN | David Levesque discusses the latest Canadian restrictions by GFN.TV
Tobacco use in U.S. prisons is akin to air, it’s ubiquitous. And like air, for the vast majority of the incarcerated the need to inhale tobacco smoke approaches desperation. Would providing access to nicotine vaping products fix the craving and maybe save lives? Find out in this interview with health and behaviour researcher Dr. Cheryl K. Olson.Featuring:Cheryl K. Olson, MPH, ScDHealth and Behavior ResearcherBehaviour Science Advisor, McKinney RSAPublic Health Columnist, Tobacco Reporterdrcherylolson.commckinneyrsa.com
GFN News #61 | WILL FRANCE BAN DISPOSABLE VAPES? | Featuring Claude Bamberger by GFN.TV
GFN News #60 | AUSTRALIA'S WAR ON VAPING | Colin Mendelsohn examines the latest vaping restrictions by GFN.TV
GFN News #59 | THAI VAPING BAN: IS THE END IN SIGHT? | Will Godfrey discusses Thailand's vaping ban by GFN.TV
Get the inside scoop on the speakers and presentations at GFN23 with Jessica Harding, program director of the Global Forum on Nicotine 2023.Featuring:JESSICA HARDINGProgram Director, Global Forum on Nicotinegfn.events@GFNicotine
0:00 - Intro with Joanna Junak0:27 - Stefan Mathisson explores the Scandinavian approach to THR3:38 - Rising influence of black market vapes8:35 - Black market vapes outcompeting competition9:42 - Swedish snus use remains high12:09 - Closing remarks
GFN News #57 | THR IN SCANDINAVIA - WHAT'S GOING ON? | Featuring Stefan Mathisson PART 1/2 by GFN.TV
0:00 - Intro with Joanna Junak0:45 - Martin Cullip discusses the UK's "swap to stop" campaign1:59 - Smoke-free UK by 2030?2:42 - Free vapes under UK government scheme4:03 - 1 million vapes to be distributed4:51 - £400 incentives to quit smoking5:39 - Will free vapes help reduce smoking rates?6:27 - Anti-vaping pushback against scheme8:03 - GFN23: What does Martin want to explore?9:12 - Closing remarks
When scientists study the chemistry of smoke versus vapor, they find a massive difference in complexity and measurable effect on the human body. Learn what those differences are in this fascinating interview with a top tobacco scientist.Featuring: Dr Marina MurphyDirector of Scientific and Medical Affairs, ANDSFormer Head of Scientific Media Relations,British American Tobacco@ands_corp
0:00 - Intro with Joanna Junak0.23 - Will Godfrey on UK government plans to achieve 'smoke free' status by 20301:47 - Flavour bans off the table2:49 - UK policy faces criticism3:46 - Closing remarks
GFN News #54 | BEHIND THE SCIENCE: SNUS AND NICOTINE | Featuring Fredrik Nyström by GFN.TV
0:00 - Intro with Joanna Junak0:55 - Barnaby Page discusses a recent survey assessing THR knowledge amongst Members of the European Parliament (MEPs)2:31 - MEPs signal shift in vaping views6:38 - MEPs shy away from heavy regulation9:28 - How do we communicate the science to MEPs?14:43 - Closing remarks
The tobacco industry is beginning to take decisive steps toward reducing the harms associated with combustible tobacco use, not by engineering a "safer cigarette" but by transforming their businesses to reduced-risk products such as vaping, oral tobacco, and heat-not-burn. In today's interview, we discuss the Tobacco Transformation Index, a tool that measures tobacco companies' progress toward a smoke-free world.Featuring:DAVID JANAZZOInt. Co-President, Foundation for Smoke-Free WorldProgram Officer, Tobacco Transformation IndexSmokefreeworld.orgtobaccotransformationindex.org@smokefreefdn
0:00 - Intro with Joanna Junak1:19 - Joel Sawa on Uganda's blanket vape ban2:40- Shifting away from smoking3:53- THR Uganda's mission for vaping education5:54- Over 10k smoking deaths annually in Uganda7:49- Uganda opposes THR reform9:31- Kenya leading THR fight in Africa13:05- Closing remarks
CHAPTERS:0:00 - Intro with Joanna Junak0:26 - Finland's struggles to catch up with Sweden1:40 - Finland inherits EU snus ban2:31 - Snus popular despite Finnish ban3:16 - Political motivation for THR in FInland3:45 - Closing remarks
CHAPTERS:0:00 - Intro with Joanna Junak0:43 - Alex Wodak discusses the latest antivaping statement by the Australian NHMRC4:02 - Calls for independent review4:58 - Systemic misuse of scientific principles6:53 - Parallels with drug harm reduction debate10:04 - Mixing ideology and science11:30 - Closing remarks
Is the science publishing industry broken? Sarah Cooney doesn't think so. Learn more in advance of her keynote at GFN23. Featuring:Sarah CooneyScientist & Science CommunicatorFormer Head of Scientific Collaboration & Communication British American Tobacco, BATDirector, Cooney Scientific Limited@SarahCooneyMcQ
GFN News #49 | WHAT NEXT FOR LATAM VAPERS? Part #2 | Leiva discusses LATAM vaping regulations by GFN.TV
Part 1 of GFN News #48 | OPPOSITION TO VAPING IN LATAM | Leiva discusses LATAM vaping regulations by GFN.TV
GFN News #47 | INDONESIA VAPING BAN | Garindra Kartasasmita discusses Indonesian vape restrictions by GFN.TV
GFN.TV Interviews | NO HESITATION | The “Old Chemist” Talks Safety & Efficacy of Vaping by GFN.TV
GFN News #46 | DENYING THE SCIENCE | Clive Bates discusses vaping science misinformation by GFN.TV
GFN News #45 | DISPOSABLE UPROAR | Will Godfrey discusses the debate around disposable vapes by GFN.TV
GFN News #44 | AUSTRALIA VAPING MISINFORMATION | Featuring Dr Colin Mendelsohn by GFN.TV
GFN.TV Interviews | BAD INFLUENCE | Misinformation & Malice Behind Taiwan Vape Ban by GFN.TV
GFN News #42 | EDUCATING CLINICIANS ABOUT NICOTINE | Featuring Dr Sud Patwardhan by GFN.TV
GFN.TV Interviews | PRISON VAPE | Impacts of THR Policy on the Scottish Prison Service by GFN.TV
GFN News #41 | STRUGGLE FOR VAPING RIGHTS IN CHILE | Featuring Ignacio Leiva of AsoVape Chile by GFN.TV
GFN News #40 | USA BATTLE FOR FLAVOURED VAPES | Featuring Alex Norcia of Filter by GFN.TV
GFN News Episode #38 | NICOTINE UNDER FIRE IN AUSTRALIA | Featuring Dr Colin Mendelsohn by GFN.TV
GFN News #37 | NICOTINE ON PRESCRIPTION | Dr Beaumont discusses Australian access to nicotine by GFN.TV
GFN News #36 | CLARITY IN COMMUNICATION | Will Godfrey discusses the importance of language in THR by GFN.TV
GFN.TV Interviews | DISCONNECT | Harm Reduction Community Struggles to Embrace THR by GFN.TV
GFN News #35 | 10 YEARS OF GFN | Featuring GFN Founders Gerry Stimson and Paddy Costall by GFN.TV
GFN's New Year Wish #8 | THE RIGHT TO ACCESS NICOTINE | John Summers and Jon Derricott by GFN.TV
GFN's New Year Wish #7 | WILL 2023 BE A YEAR OF CHANGE? | Peter Dator and Samrat Chowdhery by GFN.TV
The following music was used for this media project:Music: Happy Christmas Inspiring by WinnieTheMoogFree download: https://filmmusic.io/song/7179-happy-christmas-inspiringLicense (CC BY 4.0): https://filmmusic.io/standard-licenseArtist website: https://linktr.ee/taigasoundprod
The following music was used for this media project:Music: Happy Christmas Inspiring by WinnieTheMoogFree download: https://filmmusic.io/song/7179-happy-christmas-inspiringLicense (CC BY 4.0): https://filmmusic.io/standard-licenseArtist website: https://linktr.ee/taigasoundprod
The following music was used for this media project:Music: Happy Christmas Inspiring by WinnieTheMoogFree download: https://filmmusic.io/song/7179-happy-christmas-inspiringLicense (CC BY 4.0): https://filmmusic.io/standard-licenseArtist website: https://linktr.ee/taigasoundprod
GFN's New Year Wish #2 | 2023 - WHAT HAS TO CHANGE? | David Sweanor and Will Godfrey by GFN.TV
GFN's New Year Wish #1 | WHAT NEXT FOR THR? | Nancy Loucas and Colin Mendelsohn by GFN.TV
0:00 - Intro with Joanna Junak0:32 - What's happening with THR in Africa? We talk to Sahan Lungu1:29 - Demand for tobacco products in Africa is increasing with rapid population growth3:52 - Access to safer nicotine products in Africa: what obstacles need to be overcome?6:26 - Lack of specific safer nicotine product legislation in Malawi leads to confusion9:39 - Safer nicotine product taxes and bans introduced in several African countries11:10 - What next for THR in Africa?14:51 - Closing remarks
0:00 - Intro with Joanna Junak0:42 - Nancy Loucas of CAPHRA discusses a white paper criticism of the WHO's approach to tobacco harm reduction1:55 - White paper authors call on the WHO to honor vaping human rights obligations3:39 - Is the WHO in denial about tobacco harm reduction?4:23 - Global reliance on WHO guidance puts pressure on WHO to uphold its values6:53 - Closing remarks
0:00 - Intro with Joanna Junak0:36 - Bengt Wiberg discusses proposed snus tax increases in European Union5:35 - Why does Sweden have the right to control snus taxation?8:07 - Swedish government strongly in favour of snus-related tobacco harm reduction10:31 - Bengt Wiberg on the E.U. proposal to harmonise nicotine product taxation12:05 - Proposed snus tax increase could push people towards smoking13:40 - Closing remarks
GFN.TV Interviews | SWEDISH EXPERIENCE | Snus Maker Swedish Match on Fight for SNP by GFN.TV
0:00 - Intro with Joanna Junak 0:26 - Will Godfrey discusses divisions between tobacco harm reduction and the wider harm reduction community 2:06 - How do traditional harm reductionists view tobacco harm reduction? 4:30 - Can the harm reduction movement be unified? 5:31 - Closing remarks
0:00 - Intro with Joanna Junak 0:32 - Jon Derricott discusses the Tobacco Harm Reduction Scholarship Programme 2:24 - How do you apply to become a Tobacco Harm Reduction Scholar? 4:34 - Former Scholar Will Godfrey talks to us about the benefits of becoming a THR Scholar 5:31 - Closing remarks
0:00 - Intro with Joanna Junak 0:37 - Alex Norcia talks to us about California's ban on most flavoured nicotine products 1:23 - Bloomberg funded flavour prohibition campaign 3:09 - Martin Cullip gives his thoughts on the California flavour ban 5:15 - Martin Cullip on the failed re-election of Iowa Attorney General Tom Miller 6:53 - Closing remarks
GFN.TV Interviews | RIGHT SIDE OF HISTORY | GLOBAL STATE OF TOBACCO HARM REDUCTION by GFN.TV
The "GSTHR: The Right Side of History" report will be available at the following link from the 15th of November 2022: https://gsthr.org/resources/thr-reports/the-right-side-of-history/
0:00 - Intro with Joanna Junak 0:26 - Harry Shapiro talks to us about his newly authored report, GSTHR 2022: The Right Side of History 11:14 - The future of tobacco harm reduction and the role of governments and industry in helping to reduce smoking harms 18:46 - GSTHR 2022: The Right Side of History launches November 16th 2022 19:15 - Closing remarks
GFN News #26 | The Current State of THR in Spain featuring Dr Carmen Escrigisode #26 by GFN.TV
GFN.TV Interviews | OUTSIDE IN | Unpacking PMI’s Promise of a Smoke-Free Future by GFN.TV
0:00 - Intro with Joanna Junak 0:38 - GFN Voices with GFN 2022 guest speaker Anne Molloy, interviewed by Brent Stafford
0:00 - Intro with Joanna Junak 0:28 - Dr Roberto Sussman discusses his recent review looking at e-cigarette safety studies 10:13 - The impact of improper e-cigarette testing on toxicity data 13:21 - What can be done to improve e-cigarette safety research?
0:00 - Intro with Joanna Junak 0:30 - Dr Roberto Sussman discusses his recent review looking at e-cigarette safety studies 10:31 - Metal concentrations in e-cigarette vapour dependent on real-world applicability of testing conditions 14:41 - Unrealistic testing undermines e-cigarette toxicity research
GFN.TV Interviews | FIERCE RESISTANCE | Is Harm Reduction a Winning Argument for Vaping? by GFN.TV
0:00 - Intro with Joanna Junak 0:34 - Dr Colin Mendelsohn discusses recently introduced vaping regulations in Australia 3:05 - Real risk to vapers from black market imports 6:29 - Failed regulatory experiment requires a different approach 7:17 - Closing remarks
0:00 - Intro with Joanna Junak 0:34 - Will Godfrey discusses a recent speech by Dr Brian King 5:03 - GFN Voices featuring David Sweanor and Clive Bates
0:00 - Intro with Joanna Junak 0:51 - Dr Sudhanshu Patwardhan discusses a recent study looking at marijuana and nicotine use 5:04 - More Americans smoke marijuana than tobacco 7:52 - Nicotine use in the context of other consumable substances 12:51 - Do experts need to be better informed about a holistic healthcare approach?
GFN.TV Interviews | The Current State of Tobacco Harm Reduction in South Africa by GFN.TV
GFN News #19 | M. Cullip on the ASH guidance & J. Dunworth on the disposable vape devices by GFN.TV
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNNews #GFNVoices #RegWatchOnGFNTV
0:00 - Intro with Joanna Junak 00:21 - TODAY'S INTERVIEW IS WITH ALBERT CHAN 00:48 - RECENT EVENTS IN ASIA, ESPECIALLY CHINA 01:22 - MOST PRODUCTS USED WORLDWIDE ARE MADE IN CHINA 01:58 - JUST 10% OF PRODUCTS CONSUMED WITHIN CHINA 02:47 - NOVEMBER 2022 CHINA ANNOUNCED IT WILL REGULATE, NOT BAN 02:58 - POLICY STATEMENT MADE BY THE STATE COUNCIL 03:15 - STATE TOBACCO MONOPOLY ADMINISTRATION ANNOUNCEMENT MARCH 2022 04:55 - MAY 2022 GOVERNMENT ISSUED NEW REGULATIONS 05:36 - THE REGULATIONS ARE COMPLICATED 06:26 - A GOOD STEP FORWARD 06:52 - HEATED TOBACCO PRODUCTS DOMINATE IN JAPAN AND SOME OTHER MARKETS 07:45 - IT WILL TAKE TIME TO DEVELOP REGULATIONS FOR HTPS 09:12 - ALL ALTERNATIVE TOBACCO PRODUCTS WILL BE UNDER ONE UMBRELLA 10:27 - FACTASIA & OTHER CONSUMER GROUPS WELCOME THE MOVE 11:01 - HONG KONG BANNED VAPING IN 2022 12:28 - THE NEW LEGISLATION IS TRANSPARENT AND FAIR 13:28 - Closing remarks
Link to full Youtube show: https://bit.ly/GFNTVEp15Youtube
CHAPTERS: 0:00 - Intro with Joanna Junak 0:50 - Origins of the importation ban 3:40 - Ban widened to cover manufacture & distribution 4:29 - Consumers are fighting for their human rights 6:41 - Advocates fighting misinformation coming from public health 8:54 - Possession not illegal but vapers arrested 11:13 - Education is our primary strategy 13:32 - Despite the ban,many in the Thai parliament have switched 16:11 - Parliament is looking to change the law 19:21 - The best course is to regulate 21:30 - Black market means no control over sales 25:35 - Closing remarks
CHAPTERS: 0:00 - Intro with Joanna Junak 1:02 - Doctor John Oyston tells us why he thinks Canadian smokers need a medically licensed vaping product. 10:50 - Will Godrey of Filter is with us to discuss an innovative UK program for pregnant smokers. 14:07 - We will bring you the next part of our new series, GFN Voices. 16:42 - Brent Stafford of Regwatch interviews Federico Fernandez. 38:34 - Closing remarks
Replication Study Confirms Vapes Reduce Heart Risks Compared to Cigarettes: https://filtermag.org/replication-study-heart-vaping
High-Nicotine Vapes Don’t Increase Nicotine Use Compared With Smoking, Study Finds: https://filtermag.org/high-nicotine-vapes-smoking
0:00 - Intro 1:02 - Nancy Loucas on smoking and vaping in New Zealand today 7:45 - Recent studies support the efficacy of vaping and refute claims of harms 10:26 - Harm Reduction experts share their thoughts on youth vaping 20:58 - We introduce our new series - GFN Voices 24:22 - Brent Stafford of Regwatch interviews Lindsey Stroud 46:53 - Closing remarks
0:00 - Intro 0:55 - The Irish Heart Foundation is supporting calls to ban flavoured vapes 11:34 - There have been mixed developments over the regulation of vapes in the US 14:55 - Chimwemwe Ngoma shares his thoughts on smoking and vaping in Africa today 24:51 - GFN News is now available on SoundCloud, Spotify & Apple Podcasts 25:27 - Brent Stafford of Regwatch interviews Marewa Glover 48:08 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 21-24 June 2023. For more information, see gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
0:00 - Intro 0:55 - The Irish Heart Foundation is supporting calls to ban flavoured vapes 11:34 - There have been mixed developments over the regulation of vapes in the US 14:55 - Chimwemwe Ngoma shares his thoughts on smoking and vaping in Africa today 24:51 - GFN News is now available on SoundCloud, Spotify & Apple Podcasts 25:27 - Brent Stafford of Regwatch interviews Marewa Glover 48:08 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 21-24 June 2023. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
0:00 - Intro 0:49 - The Belgian Superior Health Council now supports vaping as a safer alternative to smoking 5:37 - FDA seems to have backed away from its decision to take JUUL off the market 8:22 - John Summers shares his thoughts on vaping in the UK today 23:48 - Brent Stafford of Regwatch intervies Brad Rodu 47:09 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 21-24 June 2023. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:40 - Mexico banned the sale of electronic cigarettes and other vaping devices 14:38 - FDA has ordered the vape company Juul to take its products off the market 17:07 - Brent Stafford of Regwatch interviews Paddy Costall 37:58 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 21-24 June 2023. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:58 - How do e-cigarettes compare to nicotine patches in helping pregnant women quit smoking? 7:12 - Will Godfrey tells us about new vape ban on the horizon 10:25 - Is Thailand becoming the next southeast asian country to welcome THR? 15:36 - Albert Chan tells us about the current situation in Hong Kong 22:17 - Brent Stafford of RegWatch interviews Fiona Patten 44:07 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:59 - Bengt Wiberg on the potential of snus and challenges faced by users outside Sweden 9:04 - Martin Cullip on confused messages about vaping from the Canadian authorities 13:08 - The Government of Kenya has revealed plans to raise excise tax on nicotine products 15:08 - Will Godfrey tells us about what happened at the E-Cigarette Summit 17:52 - Brent Stafford of RegWatch interviews Ronald Dworkin 41:27 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:56 - FDA has announced its plan to ban sales of menthol cigarettes in the USA 2:54 - Bengt Wiberg shares his thoughts on the Swedish experience of snus 14:50 - Many US physicians incorrectly believe all tobacco products are equally harmful 19:33 - Brent Stafford of RegWatch interviews Michelle Minton 41:22 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 1:03 - Canadian smokers seem to support the idea of lowering nicotine in cigarettes 7:05 - A new study has found that e-cigs are an effective quit aid for Australian smokers 12:35 - China's market regulator has released national standards for e-cigarettes 23:35 - Many doctors have misconceptions about e-cigarettes 24:15 - Brent Stafford of RegWatch interviews Sud Patwardhan 46:06 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:45 - Denmark and Sweden plans to ban nicotine and vaping products 6:59 - Government of USA is urged not to move forward with a ban of menthol cigarette 9:59 - Brent Stafford of RegWatch interviews Chim Ngoma 30:46 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 0:58 - The US Food and Drug Administration receives new powers to regulate synthetic nicotine 4:14 - In Australia, the state of New South Wales has launched a Campaign to stop young people vaping 6:25 - More tobacco harm reduction experts say that smoke-free products will help the Philippines reduce their smoking rate 8:53 - Brent Stafford of RegWatch interviews Nancy Loucas 30:58 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 1:00 - Sales of bothcigarettes and safer nicotine products to anyone born after 2005 may be banned in Malaysia 2:05 - CAPHRA is supporting the Philippines Vaporized Nicotine Product Bill 3:34 - Konstantinos Farsalinos explains why flavours are key to the success of vaping for harm reduction 5:19 - The EU Parliament has voted to adopt the final report on Beating Cancer 7:44 - Brent Stafford of RegWatch interviews John Oyston 28:20 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, GFN•TV, a broadcast arm of the GFN stable, is now offering year round coverage of the issues that matter in tobacco harm reduction.
GFNTV #GFNNews #RegWatchOnGFNTV
0:00 - Intro 1:18 - The Philippines has approved a key Vaporized Nicotine Product Bill 1:54 - What is the FDA doing regarding the regulation of vaping products in the USA? 4:44 - David Sweanor shares his thoughts on doctors and nicotine 6:32 - Study concludes vaping is aless effective quit method - but what are its limitations? 11:26 - Brent Stafford interviews prominent harm reductionist Mark Tyndall 35:18 - Closing remarks
GFN•TV is part of Global Forum on Nicotine. Join us live in Warsaw on 16-18 June 2022. For more information, see https://gfn.events
The Global Forum on Nicotine (GFN), which has taken place every year since 2014, is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, a broadcast arm of the GFN stable, GFN•TV, is set to launch this week in a new venture for the conference organisers.
Smoking Cessation with David Sweanor (Extended Interview), Figure 1's Youtube channel. For the full interview, see https://youtu.be/hAWmYQmmiQQ